Return to flip book view

2019 Program Guide

Presented by proven collaborative solutions

Welcome The 2019 Specialty Pharmacy Summit marks 15 years of continuous dedication industry collaboration thought leadership and patient centric service focused on driving progress for the specialty pharmacy channel As Asembia celebrates this milestone we thank our partners across the industry who have collaborated to drive meaningful change that improves the quality of patient care This year Asembia invites its current and prospective member pharmacies and industry partners to continue this legacy The value packed 2019 agenda is carefully designed to educate and maximize networking opportunities among the best and the brightest minds in the industry Collectively our goal remains to develop innovative programs that empower cost effective solutions to improve the patient journey Together we are Asembia

We don t just make medicine We make a difference

Our mission is to have a remarkable impact on patient s lives With a pioneering spirit a collaborative culture and unmatched determination our people deliver bold thinking and new approaches to meeting patient needs We make innovation work for people Our scientists develop and advance new drugs to have strong clinical performance and real economic value especially where needs are great like immunology oncology virology and neuroscience All we do is whatever it takes Tackling the world s toughest health challenges means following the best scientific ideas We partner with peers universities clinical experts governments non government organizations and advocacy groups worldwide to achieve better outcomes Passionate about our work Responsible in our actions We recognize and embrace our opportunity to contribute resources to improve global health Our nonprofit AbbVie Foundation helps build strong communities sustainable healthcare systems and effective educational programs AbbVie s volunteer programs demonstrate our employees deep commitment to giving back to our communities while inspiring an engaged workforce At AbbVie we see a future full of possibility 175 countries 30 000 employees 22 R D and manufacturing facilities AbbVie 1 North Waukegan Road North Chicago Illinois 60064 abbvie com US ABBV 180597 CM 0101 1018 Copyright 2018 AbbVie All rights reserved

Contents 6 AGENDA 24 WYNN ENCORE MAP SPEAKERS 28 68 SPONSORS 76 ATTENDING ORGANIZATIONS 90 EXHIBITORS

Continuing Education Meal Function Networking Opportunity ENHANCE YOUR ATTENDEE EXPERIENCE Download the Summit mobile app for the latest conference information 2019 Asembia Summit Speaker Faculty Attendee List Full Agenda Agenda Speakers Sponsors Exhibitors Attendees Maps About Summit Search Wi Fi Social Media Activity Feed Wynn App Exhibitor List Map Search for CrowdCompass AttendeeHub and search for Asembia Summit If you have any problems visit asembiasummit com mobileapp or the onsite mobile app help desk specialty pharmacy summit 7

ARISTADA IS PROVEN EFFECTIVE FOR SCHIZOPHRENIA IN ADULTS CLICK HERE TO LEARN MORE HELP YOUR MEMBERS WITH SCHIZOPHRENIA MOVE FORWARD WITH TREATMENT ON DAY 1 With one injection of ARISTADA INITIO and a single dose of 30 mg oral aripiprazole plus ARISTADA 1064 mg your members are fully dosed on day 1 for 2 months of treatment After establishing tolerability with oral aripiprazole INDICATION ARISTADA INITIO aripiprazole lauroxil in combination with oral aripiprazole is indicated for the initiation of ARISTADA aripiprazole lauroxil when used for the treatment of schizophrenia in adults ARISTADA is indicated for the treatment of schizophrenia in adults IMPORTANT SAFETY INFORMATION FOR ARISTADA INITIO AND ARISTADA WARNING INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA RELATED PSYCHOSIS Elderly patients with dementia related psychosis treated with antipsychotic drugs are at an increased risk of death ARISTADA INITIO and ARISTADA are not approved for the treatment of patients with dementia related psychosis Please see additional Important Safety Information on next page and full Prescribing Information including Boxed Warning for ARISTADA INITIO and ARISTADA

INDICATION and IMPORTANT SAFETY INFORMATION for ARISTADA INITIO aripiprazole lauroxil and ARISTADA aripiprazole lauroxil extendedrelease injectable suspension for intramuscular use INDICATION ARISTADA INITIO in combination with oral aripiprazole is indicated for the initiation of ARISTADA when used for the treatment of schizophrenia in adults ARISTADA is indicated for the treatment of schizophrenia in adults IMPORTANT SAFETY INFORMATION WARNING INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA RELATED PSYCHOSIS Elderly patients with dementia related psychosis treated with antipsychotic drugs are at an increased risk of death ARISTADA INITIO and ARISTADA are not approved for the treatment of patients with dementiarelated psychosis Contraindication Known hypersensitivity reaction to aripiprazole Reactions have ranged from pruritus urticaria to anaphylaxis Cerebrovascular Adverse Reactions Including Stroke Increased incidence of cerebrovascular adverse reactions e g stroke transient ischemic attack including fatalities have been reported in placebo controlled trials of elderly patients with dementia related psychosis treated with risperidone aripiprazole and olanzapine ARISTADA INITIO and ARISTADA are not approved for the treatment of patients with dementia related psychosis Potential for Dosing and Medication Errors Medication errors including substitution and dispensing errors between ARISTADA INITIO and ARISTADA could occur ARISTADA INITIO is intended for single administration in contrast to ARISTADA which is administered monthly every 6 weeks or every 8 weeks Do not substitute ARISTADA INITIO for ARISTADA because of differing pharmacokinetic profiles Neuroleptic Malignant Syndrome NMS A potentially fatal symptom complex may occur with administration of antipsychotic drugs including ARISTADA INITIO and ARISTADA Clinical manifestations of NMS include hyperpyrexia muscle rigidity altered mental status and evidence of autonomic instability irregular pulse or blood pressure tachycardia diaphoresis and cardiac dysrhythmia Additional signs may include elevated creatine phosphokinase myoglobinuria rhabdomyolysis and acute renal failure The management of NMS should include 1 immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy 2 intensive symptomatic treatment and medical monitoring and 3 treatment of any concomitant serious medical problems for which specific treatments are available Tardive Dyskinesia TD The risk of developing TD a syndrome of abnormal involuntary movements and the potential for it to become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic increase The syndrome can develop although much less commonly after relatively brief treatment periods at low doses Prescribing antipsychotics should be consistent with the need to minimize TD Discontinue ARISTADA if clinically appropriate TD may remit partially or completely if antipsychotic treatment is withdrawn Metabolic Changes Atypical antipsychotic drugs have been associated with metabolic changes that include Hyperglycemia Diabetes Mellitus Hyperglycemia in some cases extreme and associated with ketoacidosis coma or death has been reported in patients treated with atypical antipsychotics There have been reports of hyperglycemia in patients treated with oral aripiprazole Patients with diabetes should be regularly monitored for worsening of glucose control those with risk factors for diabetes should undergo baseline and periodic fasting blood glucose testing Any patient treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia including polydipsia polyuria polyphagia and weakness Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing In some cases hyperglycemia has resolved when the atypical antipsychotic was discontinued however some patients require continuation of antidiabetic treatment despite discontinuation of the suspect drug Dyslipidemia Undesirable alterations in lipids have been observed in patients treated with atypical antipsychotics Weight Gain Weight gain has been observed with atypical antipsychotic use Clinical monitoring of weight is recommended Pathological Gambling and Other Compulsive Behaviors Compulsive or uncontrollable urges to gamble have been reported with use of aripiprazole Other compulsive urges less frequently reported include sexual urges shopping binge eating and other impulsive or compulsive behaviors which may result in harm for the patient and others if not recognized Closely monitor patients and consider dose reduction or stopping aripiprazole if a patient develops such urges Orthostatic Hypotension Aripiprazole may cause orthostatic hypotension which can be associated with dizziness lightheadedness and tachycardia Monitor heart rate and blood pressure and warn patients with known cardiovascular or cerebrovascular disease and risk of dehydration and syncope Falls Antipsychotics including ARISTADA INITIO and ARISTADA may cause somnolence postural hypotension or motor and sensory instability which may lead to falls and subsequent injury Upon initiating treatment and recurrently complete fall risk assessments as appropriate Leukopenia Neutropenia and Agranulocytosis Leukopenia neutropenia and agranulocytosis have been reported with antipsychotics Monitor complete blood count in patients with pre existing low white blood cell count WBC absolute neutrophil count or history of drug induced leukopenia neutropenia Discontinue ARISTADA INITIO and or ARISTADA at the first sign of a clinically significant decline in WBC and in severely neutropenic patients Seizures Use with caution in patients with a history of seizures or with conditions that lower the seizure threshold Potential for Cognitive and Motor Impairment ARISTADA INITIO and ARISTADA may impair judgment thinking or motor skills Patients should be cautioned about operating hazardous machinery including automobiles until they are certain therapy with ARISTADA INITIO and or ARISTADA does not affect them adversely ALKERMES is a registered trademark of Alkermes Inc ARISTADA and logo and ARISTADA INITIO are registered trademarks of Alkermes Pharma Ireland Limited used by Alkermes Inc under license 2019 Alkermes Inc All rights reserved ARI 003600 V1 February 2019 Body Temperature Regulation Disruption of the body s ability to reduce core body temperature has been attributed to antipsychotic agents Advise patients regarding appropriate care in avoiding overheating and dehydration Appropriate care is advised for patients who may exercise strenuously may be exposed to extreme heat receive concomitant medication with anticholinergic activity or are subject to dehydration Dysphagia Esophageal dysmotility and aspiration have been associated with antipsychotic drug use use caution in patients at risk for aspiration pneumonia Concomitant Medication ARISTADA INITIO is only available at a single strength as a single dose pre filled syringe so dosage adjustments are not possible Avoid use in patients who are known CYP2D6 poor metabolizers or taking strong CYP3A4 inhibitors strong CYP2D6 inhibitors or strong CYP3A4 inducers antihypertensive drugs or benzodiazepines Depending on the ARISTADA dose adjustments may be recommended if patients are 1 known as CYP2D6 poor metabolizers and or 2 taking strong CYP3A4 inhibitors strong CYP2D6 inhibitors or strong CYP3A4 inducers for greater than 2 weeks Avoid use of ARISTADA 662 mg 882 mg or 1064 mg for patients taking both strong CYP3A4 inhibitors and strong CYP2D6 inhibitors See Table 4 in the ARISTADA full Prescribing Information Commonly Observed Adverse Reactions In pharmacokinetic studies the safety profile of ARISTADA INITIO was generally consistent with that observed for ARISTADA The most common adverse reaction 5 incidence and at least twice the rate of placebo reported by patients treated with ARISTADA 441 mg and 882 mg monthly was akathisia Injection Site Reactions In pharmacokinetic studies evaluating ARISTADA INITIO the incidences of injection site reactions with ARISTADA INITIO were similar to the incidence observed with ARISTADA Injection site reactions were reported by 4 5 and 2 of patients treated with 441 mg ARISTADA monthly 882 mg ARISTADA monthly and placebo respectively Most of these were injectionsite pain and associated with the first injection and decreased with each subsequent injection Other injection site reactions induration swelling and redness occurred at less than 1 Dystonia Symptoms of dystonia prolonged abnormal contractions of muscle groups may occur in susceptible individuals during the first days of treatment and at low doses Pregnancy Nursing May cause extrapyramidal and or withdrawal symptoms in neonates with third trimester exposure Advise patients to notify their healthcare provider of a known or suspected pregnancy Inform patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to ARISTADA INITIO and or ARISTADA during pregnancy Aripiprazole is present in human breast milk The benefits of breastfeeding should be considered along with the mother s clinical need for ARISTADA INITIO and or ARISTADA and any potential adverse effects on the infant from ARISTADA INITIO and or ARISTADA or from the underlying maternal condition Please see full Prescribing Information including Boxed Warning for ARISTADA INITIO and ARISTADA

Wynn Encore Map Badge Pick Up Registration General Session Meeting Rooms Exhibits Meals Asembia Networking Event at XS 10 specialty pharmacy summit

specialty pharmacy summit 11

Monday April 29 10 00 AM 8 00 PM Exhibit Hall Set Up Exhibitors Only Lafite Ballroom 10 00 AM 7 00 PM Registration Open Petrus 11 00 AM Sign in Lunch 11 30 AM 1 00 PM Lafleur A nalyzing the Impact of Specialty Pharmacy Services on Outcomes in Pulmonary Arterial Hypertension Speakers Matthew Casciano and Chris Ogurchak 11 00 AM Sign in Lunch 11 30 AM 1 00 PM Margaux 2 S pecialty Pharmacy Care and Cost Management Strategies for Psoriatic Disease Therapies Speakers Robin Dore Alan Menter and Michael Zeglinski 1 00 PM 2 30 PM NCPDP Specialty Sessions Leveraging Standards for Improved Outcomes Mouton Session 1 How NCPDP is Improving Speed to Specialty Therapy Speakers Pooja Babbrah and John Hill Session 2 Real Time Benefit Check The Next Revolution in Healthcare Speakers Jill Helm and Julie Hessick Session 3 Best Practices for Automating REMS in Workflow Speakers Pooja Babbrah Shivani Patel and Mark Sasala 1 30 PM Sign in 2 00 PM 3 30 PM A nalyzing Hereditary Angioedema A Review of Evidence and Treatment Approaches Speakers Mark Malesker and Cari Pao 1 30 PM Sign in 2 00 PM 3 30 PM M anaging Multiple Sclerosis A Guide for Specialty Pharmacy Professionals Speakers Harold Moses and Ed Pezalla 14 specialty pharmacy summit Lafleur Margaux 1

Continuing Education Meal Function 3 00 PM 5 00 PM All Together A Women s Leadership Forum Networking Opportunity Latour 1 4 Welcome and Introductions Speaker Suzette DiMascio What it Means to be a Pharmacist and a Mom in the 21st Century Speaker Suzanne Soliman A Business Priority How a Culture of Equality Drives Innovation Speaker Keena Patel 4 00 PM Sign in 4 30 PM 6 00 PM E xamining Therapy Health Care Utilization and Patient Management for Chronic Inflammatory Demyelinating Polyneuropathy CIDP Speakers Amy Clarke and Tuan Vu Lafleur 4 00 PM Sign in 4 30 PM 6 00 PM Margaux 1 E mploying Immuno Oncology Biomarkers to Guide Treatment Decision Making Managed Care and Specialty Pharmacist Perspectives Speakers Lisa Davis and Matthew Farber 5 00 PM 6 30 PM Poolside Welcome Reception Sunset Terrace Pool 6 30 PM Sign in Dinner 7 00 PM 8 30 PM Lafleur P CSK9 Inhibitors Managing Hypercholesterolemia and Improving Patient Outcomes Speakers Rhonda Cooper DeHoff and Joseph Saseen 6 30 PM Sign in Dinner 7 00 PM 8 30 PM Margaux 2 O pening Night Crossfire Discussions on Implications of New Advances in Diabetic Retinopathy Speakers Samit Bhatt David Boyer and Darius Moshfeghi specialty pharmacy summit 15

Tuesday April 30 6 30 AM 7 00 PM Registration Open Petrus 6 30 AM Sign in Breakfast 7 00 AM 8 30 AM Beethoven A dvancing Specialty Pharmacy s Role in the Multidisciplinary Approach to Managing Inflammatory Bowel Disease Speakers Rolf Benirschke and Christopher Owens 6 30 AM Sign in Breakfast 7 00 AM 8 30 AM Lafleur N ovel Advances in Hereditary ATTR Amyloidosis Payer and Specialty Pharmacy Considerations Speakers Sami Khella and Karen Thomas 7 30 AM 9 30 AM Buffet Breakfast Latour Ballroom Sunset Terrace 9 00 AM 9 30 AM Encore Ballroom 1 3 Transforming Specialty Pharmacy Operations to Deliver Better Patient Care Speakers James Adams and Sean Creehan 9 00 AM 9 30 AM Margaux Innovations in Oncology Specialty Pipeline Update Speakers Cheryl Allen and Florencio Calderon 9 00 AM 9 30 AM Mouton Specialty Lite An Evolving Fulfillment Model Speakers Tony Lanzone and Snehal Patel 9 45 AM 10 15 AM Encore Ballroom 1 3 How Pharmacies of Different Practice Models Provide Quality Patient Care Speakers Heather Bonome and Jennifer Richards 9 45 AM 10 15 AM Margaux Advanced Pharma Contracting The Implications of Ongoing Federal State Prosecutions Regulations Speakers Michael Hess Kirk Hunt and Dan Tardiff 9 45 AM 10 15 AM Mouton Copay Accumulator Programs Effective Tool for Managing Costs or Barrier to Patient Access Speaker Bruce Feinberg 18 specialty pharmacy summit

Continuing Education 10 00 AM 12 00 PM Exhibits Networking 10 30 AM 11 00 AM Meal Function Networking Opportunity Lafite Ballroom Encore Ballroom 1 3 Innovative Models in Limited Distribution Drug Networks Insights for Pharma Specialty Pharmacies and Payers Speakers Chris Creamer and Will Pih 10 30 AM 11 00 AM Margaux Market Disintermediation Mergers Mega Players and Media Hype Speaker Dean Erhardt 10 30 AM 11 00 AM Mouton Personalized Benefit Management in Specialty Speaker Steve Cutts 11 15 AM 11 45 AM Encore Ballroom 1 3 Evaluating and Comparing Treatment Outcomes in Specialty Care Speakers Rich Glicklich and Tom Renshaw 11 15 AM 11 45 AM Margaux What it Means to be an Independent Specialty Pharmacy in a Vertically Integrated World Speaker Paula Bickley 11 15 AM 11 45 AM Mouton A Specialty Pharmacy Pipeline Product Update Speaker Ray Tancredi 11 30 AM Sign in Lunch 12 00 PM 1 30 PM Beethoven A Virtual Reality View Moderate to Severe Atopic Dermatitis Long Term Treatment and Managed Care Issues Speakers Jonathan Silverberg and Geoffrey Wall 11 30 AM Sign in Lunch 12 00 PM 1 30 PM Lafleur E arly Interventions for Treating Influenza Economic Evaluation in Managed Care Settings Speakers Marilyn Bulloch and Sheldon Rich specialty pharmacy summit 19

Tuesday April 30 12 00 PM 1 30 PM Buffet Lunch Latour Ballroom Sunset Terrace 1 00 PM 1 30 PM Encore Ballroom 1 3 DELIVERxING Hope to Patients with Rare Diseases Improving Orphan Precision Medicine Channels Speaker Gordon Vanscoy 1 00 PM 1 30 PM Margaux Multiple Sclerosis New Perspectives on the Patient Journey 2019 Update Speaker Bruce Pyenson 1 00 PM 1 30 PM Mouton Evolution of VBC What Have We Learned and Where are We Going Speakers Lisa Carman and Gina Guinasso 1 45 PM 2 15 PM Margaux Aligning Marketing HUBs Market Access Distribution and Sales Strategies for Specialty Brands Speakers Greg Leighton and David Robinson 1 45 PM 2 15 PM Mouton Data Rules Strategies for Leveraging Data and Defining Value Based Care Speakers Champ Burgess Kristin Chambers Elizabeth Forner Diane Giaquinta and Tom Koenig 2 30 PM 3 00 PM Encore Ballroom 1 3 Streamlining Relationships Between Charitable Foundations Pharmacies to Maximize Patient Grant Usage Speakers Stacy Carmona Melissa Paige Jeffery Zobell and Krista Zodet 2 30 PM 3 00 PM Margaux Preparing for an Uncertain Future Managing Drug Spend Speakers Joseph Coppola and George Van Antwerp 2 30 PM 3 00 PM Mouton Enhancing the Physician and Specialty Pharmacy Relationship Speaker James Orsini 3 00 PM 6 00 PM Exhibits Networking 22 specialty pharmacy summit Lafite Ballroom

Continuing Education 6 00 PM 7 30 PM Meal Function Networking Opportunity Latour URAC Pharmacy Program Development Updates Meet the New CEO Speakers Heather Bonome and Shawn Griffin 6 00 PM Sign in Dinner 6 30 PM 8 00 PM Lafleur A Tech Based Open Forum for Specialty Pharmacists on the Rise and Role of Biologics for Asthma Speakers Ryan Atkinson Nicola Hanania and Diego Maselli specialty pharmacy summit 23

Sanofi is dedicated to supporting people through their health challenges We global biopharmaceutical company focused on human health We prevent vaccines provide innovative treatments to fight pain and ease suffering We s the few who suffer from rare diseases and the millions with long term chronic With more than 100 000 people in 100 countries Sanofi is transforming scientific into healthcare solutions around the globe Sanofi Empowering Life Proud to be a Diamond Sponsor for Asembia Summit 2019 www ww

e are a illness with stand by conditions c innovation w sanofi com ww sanofi us

Wednesday May 1 6 30 AM 6 00 PM Registration Open Petrus 6 30 AM Sign in Breakfast 7 00 AM 8 30 AM Beethoven E xamining von Willebrand Disease Treatment and the Role of Specialty Pharmacy Services Speakers Tim Affeldt and Sheh Li Chen 6 30 AM Sign in Breakfast 7 00 AM 8 30 AM Lafleur E xamining Peanut Allergy Pathophysiology Immunotherapy Data and Healthcare Utilization A Primer for Specialty Pharmacy Speakers Michael Blaiss and Christina Ciaccio 7 30 AM 9 30 AM Buffet Breakfast Latour Ballroom Sunset Terrace 8 30 AM 10 00 AM FEATURED BUSINESS SESSION Specialty Pharmacy Industry Outlook What s Next Speakers Adam Fein Lisa Gill and Doug Long Encore Ballroom 10 30 AM 11 15 AM GENERAL SESSION KEYNOTE Remarks from Dr Scott Gottlieb 23rd Commissioner of the Food Drug Administration Encore Ballroom 11 15 AM 11 45 AM GENERAL SESSION KEYNOTE A Conversation with Maria Shriver Activist Founder of The Women s Alzheimer s Movement Encore Ballroom 11 30 AM Sign in Lunch 12 00 PM 1 30 PM Beethoven R eviewing Clinical Therapy Advances and Management of Amyotrophic Lateral Sclerosis Speakers Sarah Dehoney and Micaila Ruiz 11 30 AM Sign in Lunch 12 00 PM 1 30 PM Lafleur C linical Updates and Cost Management Strategies in Treating Idiopathic Pulmonary Fibrosis Speakers Lisa Lancaster and Geoffrey Wall 12 00 PM 1 30 PM Buffet Lunch 26 specialty pharmacy summit Latour Ballroom Sunset Terrace

Continuing Education 1 00 PM 1 45 PM The Impact of Market Consolidation on Specialty Patients and Providers Speakers LeeAnn Mengel and Rina Shah 1 00 PM 1 45 PM Trending Policy Impacts on Specialty Drugs Speaker Jayson Slotnik 1 00 PM 1 45 PM Value Based Care Opportunities and Trends for Specialty Therapeutics Speaker Bedrick Gadea Meal Function Networking Opportunity Encore Ballroom Margaux Mouton 2 00 PM 2 45 PM Encore Ballroom Cancer Care in America A Fireside Chat with Biden Cancer Initiative President Greg Simon Speakers Greg Simon and Burt Zweigenhaft 2 00 PM 2 45 PM Margaux Then and Now Understanding the Trend Lines to 2025 and the Operational Challenges of Today Speakers John Cervione and Bill Roth 3 00 PM 6 00 PM Exhibits Networking Lafite Ballroom 6 00 PM 7 30 PM Exhibit Hall Breakdown Exhibitors Only Lafite Ballroom 9 00 PM 12 00 AM G rand Evening Reception Badges and wristbands required XS Located in Encore specialty pharmacy summit 27

Find more information at AimovigPayerResources com Visit us at BOOTH 223 2019 Amgen Inc All rights reserved USA 334 81016

Thursday May 2 6 30 AM 12 00 PM Registration Open Petrus 6 30 AM Sign in Breakfast 7 00 AM 8 30 AM Beethoven I ntegration of PARP Inhibitors for the Treatment of Ovarian Cancer Significance for Payers and Specialty Pharmacies Speakers Laura Alwan and Jason Bergsbaken 6 30 AM Sign in Breakfast 7 00 AM 8 30 AM Lafleur E valuating the Economic and Societal Challenges of Diabetic Retinopathy and Diabetic Macular Edema Speakers Eric Cannon and Dan Kiernan 8 00 AM 9 30 AM Continental Breakfast Sunset Terrace 8 00 AM 11 00 AM Exhibit Hall Breakdown Exhibitors Only Lafite Ballroom 9 00 AM 9 30 AM Encore Ballroom 1 3 Implementing Outcomes Research in Specialty Pharmacy Practice Your Value Story Speaker Autumn Zuckerman 9 00 AM 9 30 AM Patient Assistance Programs The Current Landscape and the Future Speaker Ayesha Azam Margaux 1 9 00 AM 9 30 AM Margaux 2 Challenges Opportunities Onsite Specialty Pharmacy Management for Health Systems Speaker Vaughn Kinosian 9 00 AM 9 30 AM Mouton 1 Ready for Takeoff Supporting Your Launch Strategy Operations Analytics and Performance Speakers Jeff Krol Barrett Land and Rob Ririe 9 00 AM 9 30 AM Mouton 2 OMG Patients Prefer 2 Text Successfully Adopting the Next Iteration of Patient Communication Speakers Neng Bing Doh and Alex Vinicombe 9 45 AM 10 15 AM Encore Ballroom 1 3 Return on Investment ROI vs Value on Investment VOI for Outcomes Based Contracts Speakers Tom Michalski and Kayse Reitmeyer 30 specialty pharmacy summit

Continuing Education Meal Function Networking Opportunity 9 45 AM 10 15 AM Margaux 1 Evolving Employer and Plan Sponsor Expectations to Manage Complex Specialty Products Speaker David Dross 9 45 AM 10 15 AM High Touch and High Tech Mobile Engagement in the Specialty Pharmacy Speaker Travis Baughn Margaux 2 9 45 AM 10 15 AM USP Chapters 795 797 800 Bringing it Together for December 2019 Speakers Mala Crossley and Marc Stranz Mouton 1 9 45 AM 10 15 AM Level Up The Next Stage of Medical Pharmacy Management Speaker Aaron Aten Mouton 2 10 30 AM 11 00 AM Encore Ballroom 1 3 Improving Patient Adherence though AI and the Specialty Pharmacy Channel Speakers Marc Duey and Sriram Krishnan 10 30 AM 11 00 AM Margaux 2 From Months to Minutes Increasing Speed to Therapy in the Most Challenging Prescribing Workflows Speakers Kathy Lewis Richard Prest and Amanda Robinson 10 30 AM 11 00 AM Medicines of the Future Gene Therapy Precision Medicine Speaker Cheryl Allen Chuck Collins and Paul Urick Mouton 1 10 30 AM 11 00 AM Crafting a World Class Patient Experience to Improve Outcomes and Patient Care Speakers Champ Burgess and Amy Manning Mouton 2 11 15 AM 11 45 AM Current Future Digital Health Trends Transforming the Practice of Pharmacy Speaker Harry Travis Margaux 1 11 15 AM 11 45 AM Margaux 2 Temperature Control Management for Specialty Products Pharmacopeial Updates and Best Practices Speaker Rafik Bishara 11 15 AM 11 45 AM The Evolving Landscape of Alzheimer s Disease Speaker Richard Stefanacci Mouton 1 specialty pharmacy summit 31

From patients to payers committed to evolving health care At Biogen we are committed to understanding the patient journey including the overall burden of illness to improve care We support ongoing initiatives that enable payers providers and patients to recognize the importance of different treatment options in multiple sclerosis and in emerging specialty neurology areas To learn more visit Biogen com or call 1 800 456 2255 facebook com Biogen Biogen 2018 Biogen All rights reserved 08 18 FCH US 2877 v3

Thursday May 2 11 15 AM 11 45 AM Mouton 2 Best Practices in Managing Health System Specialty Pharmacy Quality and Operational Metrics Speakers Mike Gannon Bob Leinss and Matthew Malachowski 11 30 AM Sign in Lunch 12 00 PM 1 30 PM Beethoven C hronic Lymphocytic Leukemia Evolving Treatment Strategies and the Role of the Specialty Pharmacist in Improving Patient Outcomes Speakers Victoria Brown and Kirollos Hanna 11 30 AM Sign in Lunch 12 00 PM 1 30 PM Lafleur E xamining Treatment Options in Chronic Thromboembolic Pulmonary Hypertension CTEPH A Review for Specialty Pharmacists Speakers Christopher Ensor and Rebekah Anguiano End of Scheduled Events 34 specialty pharmacy summit

Continuing Education Meal Function Networking Opportunity At Bristol Myers Squibb we are working together for patients Our mission is clear we discover develop and deliver innovative medicines that help patients prevail over serious diseases Our sense of urgency is real we work every day to push the boundaries of scientific discovery and to make a meaningful difference in the lives of patients We are committed to developing a 21st century work force that is powerfully diverse and broadly inclusive capable of discovering and developing important new medicines for patients around the world It s what we do It s why we do it LOPQ bms com 2018 Bristol Myers Squibb Company specialty pharmacy summit 35

Speakers James Adams Chief Information Officer AllianceRx Walgreens Prime James Adams is Chief Information Officer for AllianceRx Walgreens Prime His many years of healthcare experience include roles at Walgreens as Senior Director of Business Integration and Director of Business Solutions Senior Product Development Manager with CardinalHealth and consulting independently with Abbott Other roles held were Metromedia Fiber and as collaborative founder and director of Infrastructure Networks Inc He has a Clinical Psychology degree from Benedictine University Tim Affeldt Director of Specialty Infusion Operations Fairview Pharmacy Services Tim joined Fairview Pharmacy Services in 2013 Prior to Fairview he spent 18 years at the Walgreen Co as a District Pharmacy Supervisor where he led the implementation of specialty programs MTM program Diabetes programs in Minnesota He is a graduate of the University of Minnesota College of Pharmacy where he is a former Pharmacy Alumni Society board member and remains active as a mentor to first year students is involved in the Leading Change in Pharmacy program is an Adjunct Assistant Professor in the Department of Pharmaceutical care Health systems Cheryl Allen Vice President Industry Relations Diplomat Cheryl leads Diplomat s Industry Relations team in finding partnerships and crafting health care solutions Previous roles include Sr Director of Clinical Services at Sanovia Corporation Pharmacist in Charge for Oncology and Lead Pharmacist for Pain Management at Priority HealthCare She founded C Allen Associates a firm focused on managed care consulting Eden Drug Company an independent pharmacy She has her BS in Pharmacy at Samford University s McWhorter School of Pharmacy her MBA at St Joseph s University Erivan K Haub School of Business Laura Alwan Board certified Oncology Clinical Pharmacist University of Washington Medical Center and Seattle Cancer Care Alliance Laura received her PharmD degree from Butler University completed her PGY 1 residency at Jewish Hospital University of Cincinnati and completed her PGY 2 residency at Huntsman Cancer Institute She currently practices in the outpatient clinics with a focus in the women s cancer clinics the genitourinary clinic and the melanoma clinic She is residency program director for the PGY 2 oncology pharmacy residency program serves as a member of the NCCN hematopoietic growth factor panel Chris Anderson Director Quality System Cardinal Health Chris has been in the pharmaceutical wholesale distribution industry since 1987 with Baxter Allegiance and Cardinal Health Currently he created manages the Quality System He led the Cardinal Health cold chain packaging initiative that has received 4 industry awards for innovation patient safety and reuse that has saved millions of dollars in product losses and has become an industry standard He is a member of the US Pharmacopeia Packaging Distribution Expert Committee Co Chair of the USP Sub Committee and a member of the Repackaging Sub Committee Rebekah Anguiano Clinical Coordinator Specialty Pharmacy Services Clinical Pharmacist UI Health Pulmonary Hypertension Program Clinical Assistant Professor UIC College of Pharmacy Department of Pharmacy Practice Dr Anguiano s responsibilities include oversight management of specialty pharmacy services clinical operations patient management program clinic based patient medication assessments education training ongoing management of pulmonary hypertension therapies teaching research publications She holds a BS in Biology from the University of Wisconsin at Milwaukee a Doctor of Pharmacy from UIC College of Pharmacy She completed her residency training practiced at the Jesse Brown VA Medical Center as a clinical pharmacist 36 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Aaron Aten Director Clinical Account Services Magellan Health In his current role Aaron is responsible for leading strategic initiatives for both regional and national health plan clients and prospects in the management of medical pharmacy utilization trends After graduating from the University Of Toledo and receiving a doctorate in pharmaceutical sciences Aaron completed a dually accredited managed care residency program and became a board certified pharmacotherapy specialist Aaron has more than 8 years of experience in the managed care pharmacy with a focus on managing specialty pharmaceuticals Ryan Atkinson Senior Director Health Outcomes Field Team Walgreens Boots Alliance As the Senior Director Ryan Atkinson acts as a clinical liaison for a broad range of managed care clients both regionally and nationally Ryan has several years of previous healthcare experience including health systems and pharma He also has over thirteen years of customer relationship experience He holds a Doctor of Pharmacy and a MBA from Butler University Ryan is a licensed pharmacist He is also certified in CPR First Aid and Immunizations Ayesha Azam Sr Director Medical Affairs Patient Access Network Foundation Ms Azam is the Senior Director of Medical Affairs at the Patient Access Network Foundation She manages the clinical parameters of PAN s assistance programs and oversees PAN s provider and pharmacy outreach Prior to joining the PAN Foundation Ms Azam worked at the Cystic Fibrosis Foundation on a prior authorization solution and a genetic testing program Ms Azam has a Master of Science degree in Health Informatics Administration from the University of Maryland University College Pooja Babbrah Point of Care Partners Practice Lead for PBM Services Co Chair WG18 Pooja specializes in product management strategic planning and go to market strategies and execution Previously she was with DrFirst where she launched the health care industry s first certified ePrescribing platform for controlled substances She ran the Product Management team focused on new product innovation Pooja is a prior co task group leader of the NCPDP Specialty ePrescribing task group the biologic and biosimilar access and traceability task group and is currently co workgroup leader of Workgroup 18 Specialty Pharmacy Workgroup Travis Baughn Vice President Clinical Initiatives Maxor National Pharmacy Services Travis is a pharmacist with a specialized focus in clinical analytics and clinical program development Throughout his career Travis has worked with self funded PBM clients fully insured Health Plan clients and various health systems across the United States to understand pharmacy trends and create innovative solutions to contain and decrease pharmacy spend Travis current focus at Maxor is developing innovative analytics and clinical programs that drive patients to lower cost medications through member engagement tools and benefit design strategies Rolf Benirschke CEO Legacy Health Strategies Rolf Benirschke is CEO of Legacy Health Strategies a patient engagement company founder of The Grateful Patient Project As a former NFL placekicker his ten year career was nearly derailed by a life threatening battle with ulcerative colitis After a miraculous comeback he returned to play with the San Diego Chargers Following his NFL career Rolf has dedicated his life to supporting patients and is a respected leader speaker in the health care industry He works as a patient advocate and is active in supporting legislation that encourages research and innovation Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 37

Creating connections Inspired by patients Commitment to patients and innovation fueled the advancement of the Celgene portfolio from hematology and oncology into inflammatory diseases Those same principles guide our approach to making sure patients can get the essential treatments they need Market Access 2017 Celgene Corporation 09 17 US CELG170264

VISIT BOOTH 505 TO LEARN MORE Discover The Diplomat Difference We take good care of patients at every step Tailored infusion support Infusion consumer advocates have personal experience with the conditions they serve 120 limited distribution drugs We have the proven expertise to handle complex medications 94 patient adherence1 Our tailored education and support coupled with innovative technology drive exceptional patient adherence 109M third party financial assistance2 We work across conditions to ensure patients can access therapy Golfer Diplomat Patient Learn more Visit diplomatpharmacy com Copyright 2019 by Diplomat Pharmacy Inc Diplomat is a registered trademark of Diplomat Pharmacy Inc All rights reserved DPLO 238149 1902 1 Diplomat Specialty Pharmacy Adherence Reporting 2018 Average capped medication possession ratio Includes patients with at least two fills and no 60 plus day gaps between fills 2 Diplomat Funding Results 2018 Approximate Third party funding sourced by Diplomat

Speakers Jason Bergsbaken Pharmacy Coordinator Regional Oncology Services UW Health Jason s responsibilities include the coordination and standardization of cancer care among UW partners He received his Doctor of Pharmacy degree from the University of Wisconsin Madison He completed a PGY1 Pharmacy Residency and PGY2 Oncology Residency at UW Health In his current role he has been involved with the implementation of multiple practice advancements including pharmacist led oral chemotherapy management In addition to his coordinator responsibilities he practices as an oncology clinical pharmacist across UW Health adult care settings Samit Bhatt Principal Novum Rx Consulting LLC Samit Bhatt PharmD MBA has over 10 years of experience in the pharmacy industry He has held different roles which had responsibilities over specialty pharmacy strategies formulary management and physician engagement programs Samit holds a PharmD and MBA from Drake University Rafik Bishara Chair of the Pharmaceutical Cold Chain Interest Group PCCIG US Branch Parenteral Drug Association PDA During his 35 year career with Eli Lilly Co Rafik was responsible for Quality Knowledge Management Global Compendial Affairs Stability Distribution Excellence Global Product Protection Special Security Substances Controlled Substances Administration He is currently on the Pharmacy Advisory Council URAC and has served as Temporary Advisor to the World Health Organization He served on the US Pharmacopeia Expert Panel to prepare a sub chapter on Storage Transportation of Investigational Drug Products Michael Blaiss Clinical Professor of Pediatrics Medical College of Georgia Executive Medical Director of the American College of Allergy Asthma and Immunology Allergist Good Samaritan Health Center of Gwinnett Michael received his medical degree from the University of Tennessee Center for Health Sciences He was Chief Resident in pediatrics at UT Le Bonheur Children s Medical Center and completed a fellowship in allergy immunology at Ochsner Medical Foundation He was a Professor of Pediatrics Medicine at the UT Health Sciences Center head of the Pediatric Allergy Clinical Immunology Training Program at UT prior to going into a private practice at Allergy Asthma Care He served in Medical Affairs roles at Merck and Pfizer Consumer Health Care Heather Bonome Director of Pharmacy URAC Heather Bonome URAC Director of Pharmacy is responsible for the development and management of URAC s Pharmacy Quality Management accreditation programs overseeing independent advisory groups and governance committees that assist URAC in defining best practices and quality standards She s worked in the pharmacy benefit management field for nearly 15 years partnering with clients to develop sound clinical strategies and promote appropriate pharmaceutical utilization Bonome received her RPh from the University of Pittsburgh David Boyer Senior Partner Retina Vitreous Associates Medical Group Clinical Professor of Ophthalmology University of Southern California Keck School of Medicine David Boyer MD is a board certified ophthalmologist specializing in the treatment of diseases of the retina and vitreous He is Senior Partner at Retina Vitreous Associates Medical Group Dr Boyer is a Clinical Professor of Ophthalmology with the University of Southern California Keck School of Medicine He is one of the leading retinal clinical researchers in the country for new treatments in macular degeneration and diabetic macular edema Dr Boyer is a published author and lectures internationally on retinal research and the innovative approach to the treatment of retinal diseases 40 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Victoria Brown Oncology Clinical Pharmacist Humana Dr Brown is responsible for influencing oncology specialty strategy across the enterprise focusing on clinical program development and research initiatives Previously in health system practice she was the division director for oncology pharmacy services at the Johns Hopkins Hospital Prior she was the clinical pharmacy specialist for bone marrow transplant hematologic malignancies She received her Doctor of Pharmacy degree from Ohio State University and completed her pharmacy practice oncology specialty residencies at the Johns Hopkins Hospital Marilyn Bulloch Associate Clinical Professor and Director of Strategic Operations Harrison School of Pharmacy Auburn University Marilyn Bulloch Pharm D BCPS received her Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy at Rutgers and completed a post graduate pharmacy practice residency at the U of Alabama Birmingham Hospital Dr Bulloch completed her post graduate specialty residency in critical care pharmacy at Charleston Area Medical Center Dr Bulloch completed a Faculty Scholars Program in geriatrics through the U of Alabama Birmingham Geriatric Education Center She serves in leadership positions for pharmacy and interdisciplinary medical organizations Champ Burgess Vice President Specialty Pharmacy University Hospitals Health System Cleveland Ohio Champ Burgess serves as Vice President for University Hospitals Health System He responsibilities include building best in class Outpatient Pharmacy Operations as new business enterprises Champ has a proven and impressive track record in healthcare and business development His previous experiences include creating business operations that improved service delivery reduced costs and maximized reimbursement for large health systems Champ earned his Doctor of Pharmacy at UNC Chapel Hill and a Master of Business Administration Florencio Calderon Vice President Managed Care Diplomat Florencio leads a team dedicated to achieving payer sales objectives He served as a Clinical Assistant Professor at the University of South Carolina and as a consultant to payers on specialty pharmacy issues He has worked in Health Economics Outcomes Research for Bristol Myers Squibb and served as chief clinical officer for TIESRx He has held leadership roles with Walgreens Medco Health Solutions and Walmart Specialty Pharmacy He is a board certified pharmacotherapy specialist Six Sigma Green Belt He received his Doctor of Pharmacy from the University of Florida Eric Cannon Vice President Pharmacy Benefits Intermountain Specialty Pharmacy Eric is responsibile for SelectHealth Prescriptions a full service pharmacy benefit management group He received his Doctor of Pharmacy degree from Idaho State University He is an active member of the Academy of Managed Care Pharmacy has served on its board of directors He was awarded the Fellow of the Academy of Managed Care Pharmacy recognition was awarded the 2013 Professional Achievement Award by Idaho State University He also served on the Institute of Medicine of the National Academies Committee Preventing Medication Errors Lisa Carman Vice President Value Based Contracting Optum Lisa is a licensed pharmacist with 25 years of managed care experience She has held positions in commercial medical affairs within a biotech company in account management clinical support creating executing on value based contracts and building RWE analysis for private payers She worked for regional payers as a Pharmacy Director creating P T Committees clinical programs Most recently she worked for a pharmaceutical company providing support for outcomes based programs RWE analysis value based contracts She holds a PharmD from Washington State University completed an ASHP Residency with Group Health Cooperative now Kaiser in Pharmacy Administration Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 41

MS RA S PA TI EN T SU PP OR T PR OG UG DI G S PEC IAL TY DR IN DU ST RY L EA GIN NA MA G CT OF I M PA NG Y LIC NT PO NME OVER Driven to deliver innovative products and support beyond expectations AD N VA CE S IN M TI UL M CO PL P IA SC LE E NC MA L O ER AN S PE D RKE SI AN RS D IS N R EU N TE CY IG INS T OL Y OG S P UP TH OR HTS PRI CE PRE DIC TAB ILI TY ONC FE IN NO RT VA Visit us at Booth 111 2019 EMD Serono Inc US NPR 0118 0011 1 IL TI O LO IT VE Y GY DE CO VI THE CE NT RAP IES S RA CT IN G A ER T PI ES

Genentech s mission is the true mission of science committing every moment of every day to a broader charge of social responsibility and bringing innovative medicines to patients We support the future of science and medicine the scientists who dedicate their lives to it and the patients who depend on it THE FUTURE OF SCIENCE IS HERE

Speakers Stacy Carmona Director of Cystic Fibrosis Education Support Kroger Specialty Pharmacy In her current role Stacy provides resources and education to patients Her unique perspective has helped Kroger develop their Cystic Fibrosis programs She received her Communication degree from the University of California She has been a motivational speaker fundraiser and advocate for the Cystic Fibrosis Foundation She is an FDA Patient Representative an Ambassador for California Life Sciences Day gave a TEDx talk on breaking boundaries and was recognized by OC Metro Magazine as 1 of 10 women making a difference in Orange County CA Matthew Casciano Clinical Pharmacy Specialist Pulmonary University of Colorado Matt completed his pharmacy training at the University of Maryland School of Pharmacy and a pharmacy practice residency at the University of Colorado Hospital He started his career on the adult pulmonary unit at the University of Colorado Hospital and formalized pharmacy coverage of pulmonary hypertension patients He helped initiate pulmonary hypertension into the curriculum at the University of Colorado Skaggs School of Pharmacy As a referral center for PAH he is part of the Centers of Comprehensive Care at the University of Colorado Health System John Cervione Managing Partner BlueFin Consulting John is a tenured strategist in the pharmaceutical pharmacy benefit management and health information management industries who has produced award winning results for Fortune 500 and entrepreneurial healthcare companies alike He works with leaders of industry to help them rationalize their products portfolios sales targets and approaches to the marketplace John has taken clients through projects that span the product lifecycle from FDA product submissions through new product launches and product extension strategies Kristin Chambers VP Strategic Development AmerisourceBergen Kristin leads the Integrated Health Systems Outcomes Coalition focused on gaining access to payer and manufacturer networks for health system specialty pharmacies Her nearly 25 years of strategy sales operations marketing and executive management experience in the healthcare and consulting industries allows her to provide experience and the business know how to devise new concepts and execute successfully She has held senior level positions in sales marketing and operations for consulting firms major pharmacy retailers and healthcare providers Sheh Li Chen Christina Ciaccio Associate Professor and Chief Immunology and Pediatric Pulmonolgy and Sleep Medicine The University of Chicago Dr Ciaccio completed her undergraduate training in the Honors College at the University of Notre Dame her medical education at the Georgetown University School of Medicine She completed her internship residency in internal medicine her first year of Allergy Immunology training at Northwestern Memorial Hospital She finished her second year of training at Children s Mercy where she served as the Director of Informatics for the Division of Allergy Immunology and developed the Children s Hospital Information Capture and Knowledge Share app She completed a MS in Clinical Research at the University of Kansas School of Medicine 44 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Amy Clarke Specialty Infustion Group Diplomat Amy is a registered nurse with a passion for immune globulin therapy having done over 2000 intravenous and subcutaneous infusions to date Amy has provided multiple presentations on IVIG SCIG selection and administration specifics She is currently Director of Nursing Clinical Program Services for Diplomat Pharmacy s Specialty Infusion Group and is the IgNS president emeritus for the 2016 2018 term and serves as co chair for the IgNS educational development committee and contributed to the Ig Therapy Standards of Practice Chuck Collins Principal and President Healthcare Stakeholder Solutions LLC Chuck has over 29 years of career experience in the life sciences industry and also serves as a Senior Fellow to Medonomics a nonprofit nonpartisan think tank specializing in health policy finance and operations He holds a bachelor s degree in chemistry from Virginia Commonwealth University a master s degree in clinical chemistry from Old Dominion University and a master s degree of business administration in pharmaceutical marketing from Saint Joseph s University Rhonda Cooper DeHoff Associate Professor Associate Director Center for Pharmacogenomics and Precision Medicine University of Florida Gainesville Rhonda s area of research interest include coronary disease dyslipidemias hypertension and the factors that influence outcomes with cardiovascular pharmacotherapies She is interested in the area of antihypertensive drug use adverse metabolic effects including diabetes She has over 170 publications and many have been of high impact helping to define demographic clinical metabolic metabolomic and genetic and pharmacogenetic factors associated with responses to antihypertensive drugs and cardiovascular outcomes with antihypertensive therapy Joseph Coppola Managing Director Commercial Strategy Operations Deloitte Consulting LLP Joseph Coppola is a Managing Director in Deloitte Consulting s National Life Sciences Practice and is the leader of the Commercial and Market Access practice He has served biopharma medtech companies in their commercial market access pricing contracting distribution and general council functions Specific areas of experience include commercial performance and managed markets analytics and value based contracting He authored the article When the music changes so does the dance Time for biopharma to get in step with value based contracting Chris Creamer Senior Director Specialty Operations Walgreens Chris is responsible for leading strategic operations for more than 300 health system and community specialty pharmacies as well as specialty strategy at about 9500 retail pharmacies Chris joined Walgreens as a pharmacy graduate intern He has held various ascending leadership positions including pharmacy manager and pharmacy supervisor in Indiana Illinois pharmacy director for the Indiana Kentucky market and the healthcare director for the Ohio Indiana Kentucky West Virginia region Chris earned a BS in Pharmacy from Purdue University Sean Creehan President Creehan Company An Inovalon Company Sean is Founder President of creehan company the nation s leading technology and services firm in the Specialty Pharmacy market He has provided strategic consulting and leadership to his Specialty Pharmacy Supply Chain clients for over 25 years and his strategic business and technology direction has supported the successful Specialty Pharmacy business growth for start up pharmacies to Fortune 500 clients He holds a BS in Information Systems from Robert Morris University and is a graduate of the Entrepreneurial Management Program at Carnegie Mellon University Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 45

Advancing Therapeutics Improving Lives For more than 30 years Gilead has worked to develop medicines that address areas of unmet medical need for people around the world Our portfolio of medicines and pipeline of investigational drugs include treatments for HIV AIDS liver diseases cancer in ammatory and respiratory diseases and cardiovascular conditions Every day we strive to transform and simplify care for people with life threatening illnesses Gilead is a proud sponsor of Asembia Specialty Pharmacy Summit For more information please visit www gilead com GILEAD and the GILEAD Logo are trademarks of Gilead Sciences Inc or its related companies All other marks referenced herein are the property of their respective owners 2018 Gilead Sciences Inc All rights reserved UNBM0056 06 18

Speakers Mala Crossley President StranzCrossley Inc Mala held branch regional and corporate positions with home infusion and specialty pharmacy providers with responsibility for compounding As National Director of Clinical Operations for BioScrip she oversaw the sterile compounding program for more than 25 pharmacies nationwide As President of StranzCrossley Inc she is an ACHC surveyor for infusion specialty and PCAB accreditation consults to compounding pharmacies nationwide and has developed several compounding training courses Steve Cutts SVP Market General Manager Specialty Magellan Rx Management Steve leads sales account management operations and product development across the division and delivers solutions to help clients successfully manage complex specialty pharmaceuticals in one of the fastest growing areas of healthcare spending He began his career as a retail pharmacist and transitioned to managed care He earned a Doctor of Pharmacy from University of Rhode Island and serves as Adjunct Clinical Assistant Professor of Pharmacy Practice at URI mentoring 6th year pharmacy students as a preceptor Lisa Davis Professor Pharmacy Practice and Science University of Arizona College of Pharmacy Lisa Davis is Professor in the Department of Pharmacy Practice and Science at the University of Arizona College of Pharmacy Her practice is with the Early Phase Clinical Trials Program at the University of Arizona Cancer Center where she is also a member of the Cancer Prevention and Control Research Program Her research focuses on drug development drug resistance and the influence of genomics and other factors that contribute to variability in drug disposition and patient outcomes in oncology Lisa is board certified in pharmacotherapy and oncology pharmacy Sarah Dehoney Adjunct Associate Professor University of Utah I received my PharmD from Texas Tech University Health Sciences Center School of Pharmacy and completed a 2 year Pharmacotherapy residency at the Medical University of South Carolina I have practiced in many settings including the emergency department ICU inpatient outpatient areas I am a full time clinical pharmacist caring for outpatients with a variety of neurological conditions at the University of Utah Department of Neurology I see patients with ALS in a weekly multidisciplinary clinic designated as a Certified Treatment Center of Excellence by the ALS association Suzette DiMascio President Chief Executive Officer CSI Specialty Group As a thought leader industry expert frequent media contributor and sought after speaker on all things Specialty Under Suzette s leadership CSI Specialty Group has become known as the industry s preeminent Specialty Pharmacy Leadership Consulting firm offering strategic solutions to all healthcare market channels across the spectrum from health systems to manufacturers Suzette and her husband call the heart of specialty pharmacy home located in Central Florida and they are proud parents of a West Point Class of 2019 cadet Neng Bing Doh CEO Healthcrowd Bing founded HealthCrowd to reinvent healthcare communication by applying behavioral change techniques and consumer analytics mastered from her experience in the online advertising industry to healthcare Previously she was a senior executive in both business development and product functions within the digital advertising network space She started her career as a software engineer at Hewlett Packard holds a BS in Computer Science from the University of Wisconsin and a MBA from Cornell where she was a SC Johnson Merit Scholar 48 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Robin Dore Clinical Professor of Medicine David Geffen School of Medicine at UCLA Dr Dore is a board certified rheumatologist in private practice and a Clinical Professor of Medicine at UCLA She is certified as a clinical densitometrist by the International Society for Clinical Densitometry She is recognized for her contributions to patient physician education and community service including the development of Bone Builders a program devoted to educating girls and young women about the importance of healthy lifestyles in the prevention of osteoporosis She participates in research studies of medications David Dross National Practice Leader Managed Pharmacy Practice Mercer Health Benefits David is the national practice leader of Mercer Health Benefits Managed Pharmacy Practice Prior to this role David was the consulting segment leader of the Houston office of Mercer Human Resource Consulting Before joining Mercer David worked in management roles for Prudential and Blue Cross Blue Shield of SC David graduated from Vanderbilt University with a degree in Economics He also has a MBA from the University of Virginia He founded and was the first president of the Low Country Chapter of the National Association of Health Underwriters Marc Duey Founder President and CEO ProMetrics Marc Duey Founder President and CEO of ProMetrics enjoys serving the decision support needs of specialty biopharma executives with a focus on patient level data impacting prescription efficiency Mr Duey and his long tenured colleagues have developed and built numerous proprietary technology platforms for data collection aggregation integration analysis and reporting to cost effectively bring systems of record information and knowledge into systems of intelligence Keith Dunleavy Chief Executive Officer and Chairman of the Board Inovalon Dr Dunleavy has served as Inovalon s Chief Executive Officer since his organization of the company s predecessor companies in 1998 and as Chairman of the board of directors since the creation of the board in 2006 Dr Dunleavy is responsible for the overall execution of the company s business plan strategic relationships and the identification and realization of the Company s technology data and growth strategy and vision Dean Erhardt President D2 Pharma Consulting Dean brings over 30 years of strategy marketing management experience across both the consumer product and pharmaceutical arenas He spent 20 years in various corporate positions with US Healthcare Cardinal Health and Express Scripts He is the President of D2 Pharma Consulting working with over 300 manufacturers and 200 specialty pharmacies launching over 300 products Dean focuses on distribution and reimbursement initiates where D2 supports both the strategic analysis and the tactical execution to attain successful product commercialization Matthew Farber Senior Director Patient Care and Advocacy Oncology Fertility Walgreens Matt Farber is responsible for the development and implementation of Walgreens national oncology fertility and MS strategies He also works with external partners such as the Leukemia and Lymphoma Society LLS and the Oncology Nursing Society ONS Previously he worked for almost 10 years with the Association of Community Cancer Centers ACCC Matt graduated with a Master s degree in Political Management and a BA in International Affairs from The George Washington University Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 49

Novoeight is ready to go when your patients are A recombinant factor VIII for today s generation of people living with hemophilia A1 Dylan lives with hemophilia A Uptoto Up forfor up up to to 3 months months Please see Prescribing Information for complete product storage conditions P O RTA B I L I T Y FAC T OR ING IN AC T IVITY Novoeight can be stored1 Up to Novoeight PK profile achieves the needed peak levels of factor activity1 12 13 b Up to for up to 3 months Speak with your patients about their activity and appropriate prophylaxis dosing schedule14 for up to 12 months Longest room temperature storage time after reconstitution up to 4 hours at up to 86 F1 a Highest storage temperature after reconstitution up to 104 F for up to 2 hours1 a Compared with other recombinant FVIII products 2 11 a Please see Prescribing Information at NovoeightPro com for complete product storage conditions Dosing and appropriate level of activity may be different from person to person Appropriate dosing regimen and level of activity should be determined individually for each patient Novoeight is approved for routine prophylaxis every other day or 3 times weekly Please see Prescribing Information for complete dosing information 1 PK pharmacokinetics Applies similarly to other standard half life replacement factor VIII products b Indications and Usage Adverse Reactions Novoeight antihemophilic factor recombinant is indicated for use in adults and children with hemophilia A for on demand treatment and control of bleeding episodes perioperative management and routine prophylaxis to reduce the frequency of bleeding episodes The most frequently reported adverse reactions in clinical trials 1 were inhibitors in previously untreated patients PUPs injection site reactions and pyrexia Novoeight is not indicated for the treatment of von Willebrand disease Important Safety Information Contraindications Do not use in patients who have had life threatening hypersensitivity reactions including anaphylaxis to Novoeight or its components including hamster proteins Warnings and Precautions Anaphylaxis and severe hypersensitivity reactions are possible Patients may develop hypersensitivity to hamster proteins which are present in trace amounts in the product Should symptoms occur discontinue Novoeight and administer appropriate treatment Development of activity neutralizing antibodies inhibitors may occur Previously untreated patients PUPs are at greatest risk for inhibitor development with all factor VIII products Inhibitors have been reported following administration of Novoeight in PUPs If expected plasma factor VIII activity levels are not attained or if bleeding is not controlled with an appropriate dose perform testing for factor VIII inhibitors Please see Brief Summary of Prescribing Information on following page References 1 Novoeight package insert Plainsboro NJ Novo Nordisk Inc 2018 2 Eloctate package insert Cambridge MA Biogen Idec Inc 2017 3 Advate package insert Westlake Village CA Baxter Healthcare Corporation 2016 4 Adynovate package insert Westlake Village CA Baxter Healthcare Corporation 2017 5 Jivi package insert Whippany NJ Bayer HealthCare LLC 2018 6 Kovaltry package insert Whippany NJ Bayer HealthCare LLC 2016 7 Kogenate package insert Whippany NJ Bayer HealthCare LLC 2016 8 Nuwiq package insert Hoboken NJ Octapharma USA Inc 2017 9 Afstyla package insert Kankakee IL CSL Behring LLC 2017 10 ReFacto package insert Philadelphia PA Wyeth Pharmaceuticals Inc 2007 11 Xyntha package insert Philadelphia PA Wyeth Pharmaceuticals Inc 2014 12 Collins PW Fischer K Morfini M Blanchette VS Bj rkman S Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia Haemophilia 2011 17 1 2 10 13 Jim nez Yuste V Lejniece S Klamroth R et al The pharmacokinetics of a B domain truncated recombinant factor VIII turoctocog alfa NovoEight in patients with hemophilia A J Thromb Haemost 2015 13 3 370 379 14 Howell C Scott K Patel D Sports participation recommendations for patients with bleeding disorders Transl Pediatr 2017 6 3 174 180 Visit Novoeight104pro com today to learn more Novo Nordisk Inc 800 Scudders Mill Road Plainsboro New Jersey 08536 U S A Novoeight is a registered trademark of Novo Nordisk Health Care AG Novo Nordisk is a registered trademark of Novo Nordisk A S 2019 Novo Nordisk Printed in the U S A US19NEGT00027 February 2019

Speakers Adam Fein CEO Drug Channels Adam J Fein Ph D is the CEO of Drug Channels Institute a leading management educator for and about the pharmaceutical industry Dr Fein is one of the country s foremost experts on pharmaceutical economics the drug distribution system publishing hundreds of articles He is regularly quoted in publications such as The Washington Post The Wall Street Journal The New York Times and Forbes He is most known for his popular influential website DrugChannels net the go to source for definitive comprehensive industry analysis delivered with a witty edge Bruce Feinberg Vice President Chief Medical Officer Cardinal Health Specialty Solutions Dr Bruce Feinberg serves as Chief Medical Officer for Cardinal Health Specialty Solutions He was previously the founder and CEO of Georgia Cancer Specialists GCS one of the largest integrated oncology specialty practices in the southeastern US He maintains his license as a board certified medical oncologist in Georgia where he practiced for 25 years after completing his fellowship at M D Anderson Cancer Center A highly sought after speaker Dr Feinberg is the author of the bestselling Breast Cancer Answer and is also host of The Weekly Check Up on Atlanta s WSB Radio Elizabeth Forner Director of National Oncology Pathway Strategy Eisai Liz leads Eisai s national oncology pathways and value strategy Her focus is toward the largest oncology delivery systems in the country Liz has more than 17 years of pharmaceutical experience With a passion for large account management over half of her tenure is in critical care institutional sales and oncology Before pharma Liz worked as a health educator with the Michigan Department of Public Health Liz earned a BS in biological and biomedical sciences from Grand Valley State University Bedrick Gadea Partner The Dedham Group Bedrick helps oversee areas such as client relations business operations firm development business development and project execution He holds a doctorate from Harvard Medical School in cancer research and was a post doctoral fellow at Memorial Sloan Kettering Cancer Center and the American Cancer Society He has spent the last 12 years working in strategy consulting particularly helping manufacturer clients develop strategies Mike Gannon Business Coordinator Specialty Pharmacy Services University of Illinois Hospital and Health Sciences System Mike is currently the business coordinator for Specialty Pharmacy Services at the University of Illinois Hospital and Health Sciences System UI Health He is responsible for limited distribution drug access payer network access and internal external reporting Prior to starting at UI Health Mike was a product development pharmacist for CVS Specialty He completed a managed care residency with CVS Specialty in 2016 and graduated from University of Illinois College of Pharmacy in 2015 Diane Giaquinta President StrategiCare Diane s consulting areas of expertise are in product commercialization strategies for managed markets She frequently moderates advisory panels WebEx s engaging participants to provide insights into their practice their perceptions of the product s discussed potential formulary placement Previous roles include VP of Health Systems Management at Bristol Myers Squibb VP GM of Wellpoint Pharmacy Management She is a Past President of the AMCP and was instrumental in the creation of the association 52 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Lisa Gill Managing Director J P Morgan Securities Lisa has been a leading member of the healthcare equity research team for 17 years She is a CPA and has over 20 years of diversified healthcare experience Since 2001 she has been a Sr Publishing Analyst and is responsible for coverage of 16 companies within healthcare services Her career began with Ernst Young s audit group where she earned her CPA She then worked in Coopers Lybrand s healthcare services consulting group She was a Director of Development at Health Partners where she acquired physician practices in NYC prior to joining JP Morgan Rick Glicklich CEO OM1 Inc Rick is CEO of OM1 an outcomes technology company focused on using deep clinical data advanced analytics to measure and predict health outcomes for real world evidence and value based care He is also leading Outcomes Measures Framework a federally funded effort to standardize health outcomes measurement across and within conditions He was founder CEO of Outcome acquired in 2011 and an investor in healthcare IT with General Catalyst Partners He is a graduate of Yale University He is also a graduate surgeon and professor at Harvard Medical School Shawn Griffin President and CEO URAC Shawn Griffin M D joined URAC as president CEO in February 2019 with extensive experience in quality measurement and analytics for physician and hospital quality improvement Most recently he was VP for Clinical Performance Improvement and Applied Analytics at Premier Inc Previously as Chief Quality and Informatics Officer for MHMD Memorial Hermann Physician Network he directed the quality measurement and data collection programs for one of the largest and most successful ACOs in the country Nicola Hanania Associate Professor of Medicine Section of Pulmonary and Critical Care Medicine Director Asthma and COPD Clinical Research Center Baylor College of Medicine Nicola completed his medical training at the University of Jordan followed by a residency in Internal Medicine and fellowship in Pulmonary Medicine at the University of Toronto He subsequently completed a fellowship in Critical Care Medicine at Baylor College of Medicine and a master s degree in clinical investigation He is Principal Investigator for the American Lung Association Airway Clinical Research Center at Baylor College of Medicine as well as Principal Investigator or Co Investigator in several clinical trials in asthma and COPD Kirollos Hanna Assistant Professor of Pharmacy and Hematology Mayo Clinic College of Medicine and University of Minnesota Medical Center Dr Hanna completed his doctorate of pharmacy from Florida A M University general residency at St Thomas Hospital oncology residency at St Luke s Mountain States Tumor Institute He is an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine practices Hematology Oncology pharmacy at the University of Minnesota Medical Center Mayo Clinic He serves on the Executive Council for the National Oncology Community Dispensing Association is President Elect for the Southern Affiliate Chapter of the Minnesota Society of Health System Pharmacists Jill Helm Vice President Solution Management Veradigm Jill serves as VP Solution Management for Veradigm an Allscripts business unit and a leader in providing nextgeneration healthcare data solutions and systems During her 19 year career at Allscripts Jill has overseen the growth and evolution of electronic prescribing from its earliest stages to the complex and mission critical technology it is today Prior to her time at Allscripts Jill held management positions with Caremark now CVS Health Maxicare Health Plans and Baxter She holds B S in Pharmacy and Doctor of Pharmacy degrees from the University of Michigan Ann Arbor Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 53

Driving better results Our one of a kind approach to specialty pharmacy puts the patient at the center of everything we do while our specialty expertise and innovation position us to help Reduce costs and manage specialty trends Improve health outcomes Enhance patient experience by providing convenient care options For more information visit Walgreens com HealthSolutions 2019 Walgreen Co All rights reserved 946233 6271

Speakers Erin Hendrick Vice President of Hospital Strategy Shields Health Solutions Prior to joining Shields Health Solutions Erin was COO at Emory University Hospital Midtown Past leadership roles include Emory Healthcare University of Wisconsin Hospitals and Clinics HCA and McKesson She is a Board Certified Pharmacotherapy Specialist and a fellow of the American Society of Health System Pharmacists She earned a BS degree from the University of Wisconsin Madison and Doctor of Pharmacy and Master of Science in Health System Pharmacy Administration degrees from Ohio State University She is a graduate of the Health System Pharmacy Administration Residency Program at OSU Wexner Medical Center Michael Hess Chair Specialty Pharmacy Pharmaceutical Practice Group Bass Berry Sims Michael Hess is Bass Berry Sims PLC Specialty Pharmacy Pharmaceuticals Practice Group Lead With a reputation as a go to lawyer in the specialty pharmacy industry his impactful advice is rooted in his first hand experience as former Chief Counsel VP of Strategic Development of Accredo Health former Assistant General Counsel of Medco Health and as a private practice industry attorney his guidance helps manufacturers and pharmacies get high cost specialty drugs from the manufacturer s warehouse to the patient s door John Hill Executive Vice President GM NCPDP John W Hill MBAHCM is Executive Vice President and GM with the National Council for Prescription Drug Programs NCPDP Under the direction of the President and CEO Hill oversees and is responsible for all day to day business of the organization and leads the executive management team in achieving financial goals and operational performance and provides strategic support to NCPDP s President and CEO Kirk Hunt Assistant General Counsel Pricing Reimbursement and Access Eli Lilly Company Kirk has served as in house counsel for mid size and large pharmaceutical manufacturers providing legal advice and counsel and is currently supporting Lilly s Managed Healthcare Services group Kirk has practical expertise on the laws rules regulations and programs pertaining to the development manufacture sale and distribution of pharmaceutical products At Lilly Kirk has been the lead attorney supporting marketed and pipeline products developed to treat or diagnose Oncology Neuroscience and Neurodegenerative diseases Sami Khella Professor and Chief Department of Neurology Penn Presbyterian Medical Center Professor of Clinical Neurology University of Pennsylvania Sami graduated from the University of Pennsylvania School of Medicine Before medical school he studied biology fine arts at Penn Over 20 years ago he co founded the Penn Amyloid Center which has grown into one of the biggest Amyloid programs in the US He has been involved in the pivotal hereditary Amyloid TTR clinical trials He is the author or co author of many papers detailing this disease as well as other neuromuscular diseases particularly myasthenia gravis chronic inflammatory demyelinating polyneuropathy Dan Kiernan Ophthalmologist and Vitreoretinal Surgeon Ophthalmic Consultants of Long Island Daniel is a board certified ophthalmologist specializing in medical surgical retina diseases He holds a bachelor s in biology from University of Chicago a doctorate in medicine from Chicago Medical School Rosalind Franklin University completed his residency in ophthalmology at University of Chicago Hospital Pritzker School of Medicine He is a member of professional societies including American Society of Retinal Surgeons Association for Research in Vision Ophthalmology Pan American Association of Ophthalmology and American Academy of Ophthalmology 56 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Vaughn Kinosian Vice President Operations ReCept Healthcare Services In his current role Vaughn leads Store and Pharmacy Operations as part of the organization s vision to execute its growth strategy Previously he spent 16 years with CVS Caremark in Specialty and Retail Operations His most recent role was in the Retail Strategic Product Development group leading projects to advance CVS specialty pharmacy and inventory management priorities He also served as Director of Specialty Operations Vaughn received a BS in Pharmacy from the University of Rhode Island Sriram Krishnan Executive Vice President Growth and Artificial Intelligence Solutions Dr Krishnan is responsible for the development of new products solutions He has over 20 years of experience in healthcare IT data integration and machine learning has over 28 patents 30 peer reviewed papers and invited to several talks at major conferences on healthcare analytics During 15 years at Siemens Healthcare he helped develop artificial intelligence solutions by mining claims clinical and genomic data He led the advanced analytics practice for healthcare and life sciences at KPMG He holds a PhD in electrical engineering from the University of Michigan Tom Koenig Executive Director Biosimilar Market Access Boehringer Ingelheim Tom Koenig is responsible for the commercial development and implementation of market access strategies for biosimilar candidates Tom has had a diverse background that includes leadership roles in market access account management payer marketing and sales management during his 20 plus year career Previously Tom served as senior director of payer and market access strategy at Biogen where he was responsible for market access strategies in support of the launch of two new hemophilia therapeutics and Alzheimer s disease pipeline products Jeff Krol Greenwich Biosciences Jeff is a goal driven individual who has experience in sales management and marketing within the pharmaceutical industry Proven leader who develops people and teams that are motivated and achievement oriented A strategic thinker who creates innovative solutions to complex problems and has the ability to successfully execute the solution Strong speaker presenter and communicator with an expertise in managed markets and organized customers within many therapeutic areas Lisa Lancaster Associate Professor of Medicine Vanderbilt University Medical Center Dr Lisa H Lancaster graduated summa cum laude from the University of Georgia She graduated from the Medical College of Georgia as a member of AOA honor society She trained in Internal Medicine at Vanderbilt University from and completed a Pulmonary and Critical Care Fellowship at Vanderbilt University She is board certified in Internal Medicine Pulmonary Medicine and Critical Care Medicine She has directed the Vanderbilt IPF clinical trials center and Interstitial Lung Disease Center and been a leader in clinical trial enrollment since that time Barrett Land Greenwich Biosciences Barrett Land is a strategic leader focusing on US Pricing Trade and Contract Life Cycle Management His experience spans 15 years in Pharma where he has aligned people process and technology to drive down operating costs while standardizing processes and increasing compliance He has successfully led multiple transformational projects throughout his career Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 57

Visit us at booth 404

WE ARE THE BOOSTER ENGINE FOR YOUR SPECIALTY PHARMACY ROCKET GET THE SPEED YOU NEED FROM YOUR AMBULATORY PHARMACY STRATEGY With over a half century of pharmacy experience working inside health systems we understand the unique ambulatory environments of each hospital we serve We leverage our tools and expertise to deliver exceptional results within these focus areas Specialty Pharmacy Strategy Implementation and Accreditation Ambulatory and Retail Pharmacy Strategy and Implementation Infusion Strategy and Implementation contactus cpspharm com 800 968 6962 cpspharm com

Speakers Tony Lanzone Partner Corsica Life Sciences Consulting Tony Lanzone is a Partner with Corsica Life Sciences LLC and co leads the firms market access and distribution strategy practice Tony brings 25 years of health care experience to this role ranging from sales at a top five pharma company to management consulting roles with both Big 4 and private equity owned firms He leverages this and over 15 years of access reimbursement and distribution experience serving clients Tony received his BA in business from Franklin Marshall College and MBA from The College of William and Mary Mason School of Business Greg Leighton Senior Director of Patient Support Operations and Compliance Asembia Greg oversees the clinical operations and compliance departments for Asembia s Patient Support Centers With over a decade of pharmacy practice and product access experience he leads a clinical team in providing high quality patient care Prior to Asembia he has several years of experience working within hospital community and specialty pharmacy locations He is Medication Therapy Management Certified through the American Pharmacist Association and has received his PharmD from St John s College of Pharmacy and Allied Health Professions Bob Leinss Account Implementation Manager Acentrus Specialty Before joining Vizient as a senior consultant in the retail specialty pharmacy market he was with Froedtert Health where he spearheaded their specialty pharmacy program In his Vizient consulting position he provided business planning and implementation guidance to health systems looking to initiate or expand their ambulatory specialty pharmacy program In his current role as Account Implementation Manager for Acentrus Specialty he provides guidance and operational solutions to his clients to help them grow their specialty pharmacy programs Kathy Lewis Director Specialty Prescriptions Surescripts At Surescripts Kathy is responsible for specialty medication product strategy direction execution business direction for the accelerator technology platform leadership for a team of business analysts and Surescripts participation in Carequality Prior to joining Surescripts Kathy was Enterprise Account Executive for McKesson Provider Technologies where she was accountable for C suite relationships for their largest IDN integrated delivery network client and for assisting the IDN to achieve Meaningful Use Stage 1 and improve adoption of clinical solutions Doug Long Vice President Industry Relations IQVIA Doug Long is VP of Industry Relations at IQVIA formerlyQuintilesIMS the world s largest pharmaceutical information company He is a frequent industry speaker the recipient of the 2016 IFPW Leadership Award 2011 Harold W Pratt Award 2004 HDMA NEXUS Award for lifetime achievement 2003 IMS prestigious Summit Award and 2013 IMS CEO Team award Before IMS Health he held positions at Nielsen Market Research in various sales marketing capacities He received a BA from DePauw University holds an MBA in Management from Fairleigh Dickinson University Matthew Malachowski Supervisor Specialty Pharmacy Services UAB Medicine UAB Health System Matthew s professional responsibilities include clinical guidance and decision making for the Patient Management Program as well as oversight of the Ambulatory Division s clinic based pharmacists He functioned as the Senior Clinical Staff member during the Pharmacy s previous accreditations and serves as one of the Ambulatory Division s Industry Liaisons He graduated from the University of Rhode Island and completed a general practice residency at the University of Alabama Birmingham 60 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Mark Malesker Professor School of Pharmacy and Health Professions Creighton University Mark holds a BS in Pharmacy a PharmD from Creighton University a Cardiovascular Research Fellowship with Creighton University Cardiac Center He is currently a Clinical Pharmacy Specialist with the Pulmonary Medicine Critical Care Service at Creighton University Medical Center He is a board certified pharmacotherapy specialist a fellow of the American College of Chest Physicians American College of Critical Care Medicine American College of Clinical Pharmacy and the American Society Health Systems Pharmacists Amy Manning President Chasm Associates LLC Certified Customer Experience Practitioner with over 15 years of success in designing and delivering world class customer experiences Demonstrated ability in translating global customer needs into tangible and highly profitable solutions Amy has fostered innovation across industries Fortune 100 s and non profits to inspire possibilities Highly effective communicator and cross organizational manager committed to leveraging strengths and building consensus Driven by service her passion and expertise strategically cultivates organizational reform Diego Maselli Associate Professor of Medicine Division of Pulmonary Diseases Critical Care University of TX Health Science Center Director Respiratory Care Director Severe Asthma Program University Health System Dr Maselli completed his residency in Internal Medicine He completed fellowships in Pulmonary Diseases and Critical Care at the University of Texas Health Science Center remaining as part of the faculty He started the Severe Asthma Program at the University Health System and University of Texas Health Science Center The Severe Asthma Program focuses on asthma education treatment of asthma comorbidities and advanced therapies for severe asthma His research focuses on severe asthma non cystic fibrosis bronchiectasis and COPD LeeAnn Mengel Vice President Baptist MD Anderson Cancer Center LeeAnn is responsible for strategy and operations of the cancer and works in a dyad relationship with the cancer center medical director Her career began at Baptist Health as a Pediatric Oncology Nurse She received her BS degree in nursing from Florida State University and later obtained an MBA She is a member and fellow of the American College of Healthcare Executives Member and Board Certified with the Medical Group Managers Association member of the Association of Cancer Executives and a member of Oncology Nursing Society Alan Menter Chair Dermatology Baylor Scott White Dr Alan Menter completed 2 fellowships in London at Guy s Hospital and St John s Hospital for Diseases of the Skin and a fellowship with the University of Texas Southwestern Medical Center He was appointed chairman of the Division of Dermatology at Baylor University Medical Center director of the Baylor Research Center and Program Director of the newly formed Dermatology Residency Program at Baylor University Medical Center He founded the International Psoriasis Council His clinical practice currently includes more than 1 800 patients on systemic and biologic therapy Tom Michalski Manager Pharmaceutical Manufacturer and Contract Management Blue Cross Blue Shield of Michigan In his current role Tom serves as the lead business liaison for pharmaceutical manufacturer relationships and is responsible for pharmaceutical contract management In collaboration with Highmark Tom has led the establishment BCBSM s outcomes based contracting program He has over 30 years of experience in pharmacy and the pharmaceutical industry His diverse background includes roles in pharmacy marketing product management and business development Tom earned a BS degree in pharmacy and an MBA from Wayne State University Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 61

Informing strategies you depend on Performing services you need ALL WITH THE PATIENT IN MIND Meet EVERSANA a catalyst that disrupts the status quo and accelerates commercial success EVERSANA COM A Diagnosis Unlike Any Other Deserves A Pharmacy Unlike Any Other Let us show you why more providers health plans and pharmaceutical manufacturers are choosing Onco360 Visit Us at Booth 516 Oral Injected Infused Medications 877 662 6633 Onco360 com

A RELIABLE EXPERIENCED PRODUCER OF PLASMA DERIVED MEDICINES For more than 75 years Grifols has worked to improve the health and well being of people around the world With the world s largest network of plasma donation centers Grifols is a leading producer of essential plasma derived medicines for the treatment of rare and chronic conditions A FRACTIONATION CAPACITY OF MILLION LITERS OF PLASMA PER YEAR 13 9 MORE THAN DONATION CENTERS 190 PLASMA IN THE UNITED STATES AN AVERAGE OF MORE THAN PER DAY 30 000 DONATIONS Learn more about Grifols at www grifols com

Speakers Harold Moses Associate Professor of Neurology Neuroimmunology Division Vanderbilt University Dr Moses is an Associate Professor in the Department of Neurology at Vanderbilt University Medical Center and currently practices at the Vanderbilt Comprehensive Multiple Sclerosis Center He serves on the Professional Advisory Committee of the National Multiple Sclerosis Society and is a member of the American Academy of Neurology He has participated in a number of multicenter clinical trials in MS and is published in journals such as Neurology the Journal of Neurology the Journal of Neuroimmunology and the Proceedings of the National Academy of Science Darius Moshfeghi Professor of Ophthalmology Director of Retina Horngren Family Vitreoretinal Center at the Byers Eye Institute Department of Ophthalmology Stanford University School of Medicine Darius was the founding director of the Stanford Vitreoretinal Surgery and Medical Diseases Fellowship He is the Founder and Director of Stanford University Network for Diagnosis of Retinopathy of Prematurity and leads the Newborn Eye Screen Testing program and Global Universal Eye Screen Testing programs at Stanford University He is actively involved in entrepreneurial activities serving as a founder of Pr3vent dSentz Promisight Visunex and Versl and leading the scientific advisory board for Visunex He serves on the Board of Directors of 1800 Contacts Christopher Ogurchak Senior Professional CVS Specialty Christopher Ogurchak has a diverse blend of industry experience beginning his career in independent retail pharmacy management before transitioning to a role as a specialty pharmacy clinician During this time he earned his MS in Pharmacy Business Administration from the University of Pittsburgh In this position he strategized and implemented novel programs to drive value to all stakeholders He is a frequent contributor to Specialty Pharmacy Times and holds the CSP Certification through the Specialty Pharmacy Certification Board James Orsini Director of Oncology Clara Maass Medical Center Founder Essex Oncology Dr Orsini completed his residency at the University of Medicine Dentistry of NJ and completed oncology fellowships at Newark Beth Israel Medical Center and Mt Sinai Medical Center He was appointed to the University Hospital Board of Directors and currently serves on the Quality Care Strategic Planning Audit and Governance Ethics Committees He was recently appointed to the Physician s Practice Review Panel of the New Jersey State Board of Medical Examiners He has an office in Bologna Italy as a result of his affiliation with world renowned tenor Andrea Bocelli Christopher Owens Associate Vice President for Health Sciences Idaho State University Dr Christopher Owens PharmD MPH is Associate VP for Health Sciences at Idaho State University and holds a faculty position in the College of Pharmacy He is an adjunct instructor for U of Florida Online Master s Program in Pharmaceutical Outcomes Policy a past clinical coordinator for Idaho s Drug Utilization Review Program with ID Medicaid a past president of the AACP Pharmacy Ethics Special Interest Group His has been published in the Journal of the America Pharmacists Association Journal of Managed Care Pharmacy and The American Journal of Medicine Melissa Paige Patient Access Principal Coordinator University of Virginia Health System Melissa is responsible for patient access integration within the HCP and implementing patient access programs across the spectrum She is part of a collaborative team responsible for Pharmacy Patient Medication Assistance across the entire hospital She draws on her end to end pharmaceutical knowledge and experience to navigate the health care system She specializes in process improvements for increased cost savings and time management continually seeking out new and better methods to provide superlative quality in the care of patients 64 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Cari Pao Senior Director Health Outcomes Walgreens Boots Alliance Dr Pao has extensive experience in the health care industry from a clinical pharmaceutical managed care perspective For the 7 years she has been with the Walgreens Health Outcomes team a group of clinical pharmacists responsible for assisting clients in managing their pharmacy spend while maintaining quality patient care Previously she was in a similar clinical role with US Oncology working with providers She holds a PharmD from Shenandoah University Bernard J Dunn School of Pharmacy and her MS MBA from Marymount University Keena Patel Patient Services Practice Lead Accenture Keena Patel is a Managing Director in Accenture s Applied Life Sciences Solutions practice focused on helping clients find new value through beyond the pill patient and provider services She s keen on helping manufacturers create a new vision for how they engage with patients and providers delivering consistent and personalized experiences that are human centered keeping in mind what really matters to the end customer Keena is also responsible for Accenture s annual patient and provider services research bringing new insights to the market Shivani Patel Senior Vice President Clinical Operations Technology Asembia Shivani leads the Asembia1 technology initiative at Asembia including overseeing system deployment integrations application design and sales Her previous experience includes managing pharmacy operations and business development at QPharmacy as well as managing the Compliance Persistency program and specialty operations as Clinical Specialty Pharmacist Team Lead at CVS Health Shivani began as a staff pharmacist at Stop Shop pharmacy after receiving her PharmD from Rutgers University Ernest Mario School of Pharmacy Snehal Patel Vice President Pharmacy Access Solutions Asembia Snehal oversees the client engagement team and Asembia s Specialty Pharmacy Network for patient access data programs Prior to this role Snehal worked as the Sr Director of Clinical Operations overseeing Asembia s Patient Support Center Snehal also served as a Health Systems Pharmacy Manager supervising pharmacy operations and business development for Walgreens Specialty on site location in addition to developing pharmacy adherence and compliance programs Ed Pezalla CEO Founder Enlightenment Bioconsult LLC as a leading innovator in payer strategy for pharmaceutical device manufacturers focused on unlocking the value of innovative pharmaceutical products by developing industry leading approaches to incorporating payer requirements into development programs tech assessment plans value frameworks He works with a variety of policy industry groups on cutting edge coverage policy innovations in value based payments adaptive regulatory market entry pathways He is the former VP for Pharmaceutical Policy Strategy in the Office of the Chief Medical Officer at Aetna Will Pih Principal and EVP of Specialty Commercialization Two Labs As the lead for most specialty new product launches he guides projects specializing in creative market access channel development and lifecycle management strategies With a background as a health system and managed care pharmacy director he moved to the pharma industry and worked at companies such as Roche Genentech and Amgen He was the original founder of the Huntington Consulting Group and BioSys Laboratories Inc He received his PharmD and undergraduate education coursework in Economics from the University of Southern California Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 65

BOOTH 411 Insights to Drive Brand Success and Improve Patient Outcomes ProMetrics delivers comprehensive insights into your patient s healthcare experience Built on our strong foundation of data management and using advanced statistical models and machine learning we leverage disparate patient level datasets to deliver actionable views into the patient journey This enables you to help patients get on therapy more quickly and stay on therapy longer Specialty Channel Insights Patient Journey Analytics Data Management Visit us at www prometrics com

We re driven to improve people s lives Since our founding in 1781 Takeda Pharmaceuticals is committed to bringing better health and a brighter future to people worldwide through leading innovation in medicine www takeda us Takeda Pharmaceuticals U S A Inc

Speakers Richard Prest Senior Executive Vice President Corporate Strategy AssistRx Richard ensures that the enterprise strategy and program deliverables of AssistRx are aligned with the goals of customers and partners including healthcare providers and biopharmaceutical manufacturers As part of his mission to help people live their healthiest lives he drives a strategic focus at AssistRx to ensure solutions provide differentiated value in simplifying the complex process of enabling speed to therapy and improving patient outcomes In his role he leads key functional areas including product adoption marketing provider sales and strategic alliances Bruce Pyenson Principal Consulting Actuary Milliman Inc Bruce has consulted to almost every sector of the healthcare industry He was appointed a Commissioner of the Medicare Payment Advisory Commission serving in a position reserved for an actuary Bruce is adjunct clinical associate professor of New York University s College of Global Public Health He serves on the Board of the International Early Lung Cancer Action Program He was on the board of the Health Project Koop Awards Bruce has co authored more than 30 peer reviewed publications and has authored several Milliman research reports Kayse Reitmeyer Manager Pharmaceutical Manufacturer Relations and Rebate Administration Highmark Kayse received her bachelor s degree in Public Health from Slippery Rock University and is currently pursuing her MS in Health Informatics She began her career at the University of Pittsburgh s Department of Biomedical Informatics focusing on pathology informatics medication adherence and adverse drug event research She has been at Highmark for 5 years and works closely with pharmaceutical manufacturers on rebate negotiations and Highmark s clinical pharmacy team to develop formulary strategy Tom Renshaw Senior Director of Business Solutions Acentrus Specialty Tom Renshaw currently functions as the Senior Director of Business Solutions for Acentrus Specialty with responsibility for innovative business strategies and development He has served as a subject matter expert in the areas of contracting transitional care population health management informatics 340B and clinical software development Sheldon Rich President SJR Associates LLC Adjunct Clinical Associate Professor University of Michigan Sheldon J Rich R Ph Ph D is President of SJR Associates which provides consulting services to managed care organizations physician practice groups employers pharmaceutical manufacturers He earned his pharmacy degree from the University of Michigan and Doctorate in Theocentric Business Ethics Dr Rich has served as Clinical Assistant Professor at the University of Michigan and has held a dual appointment as Adjunct Assistant Professor with the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University Jennifer Richards Pharmacy Accreditation Reviewer URAC Jenn Richards PharmD J D is a pharmacy accreditation reviewer at URAC She has pharmacy background in retail prescription benefits management specialty compounding and hospital Jenn has worked on many pharmacy improvement projects making large changes to organizational structures to provide better total patient care Jenn has a Doctor of Pharmacy received in 2011 and a Juris Doctor received in 2015 68 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Rob Ririe Partner Pherocity Consulting Rob is a proven practitioner within the life science industry including strategic planning business process design and implementation pricing sales and sales management He brings over 20 years of industry experience Prior to founding Pharosity Consulting with Brian Barbash and Mike McCarthy he co led the Managed Markets practice for Blue Fin Group and gained valuable experience working at Coopers Lybrand PwC IBM and IMS Health He spent 10 years at Wyeth Ayerst Laboratories which provides him with a unique balance of industry and consulting perspectives Amanda Robinson Access Manager Fairview Pharmacy Solutions Amanda Robinson is the Manager of Access Services at Fairview Specialty Pharmacy a large regional specialty pharmacy provider in Minneapolis MN In her current role she oversees centralized PA services including electronic PA s and patient financial assistance programs for both external and internal specialty patients and internal primary care clinic patients Amanda is a nationally certified pharmacy technician has extensive experience in home infusion and has worked in pharmacy for the last 10 years David Robinson Partner Protean LLC David has over 30 years of general management marketing sales field access reimbursement leadership experience with emerging and global biotechnology pharmaceutical companies His leadership propelled the launch of multiple biologic blockbuster brands and indications in ophthalmology dermatology cardiology rheumatology and Crohn s disease He has led and supported the launch of 15 major small molecule brands across oncology gastroenterology HIV David has held leadership positions at Regeneron UCB MedImmune and GlaxoSmithKline Bill Roth Founding Partner Blue Fin Group Bill is a recognized expert in business model development in the healthcare industry For over 25 years he has helped both start ups industry leaders gain focus and traction to improve strategic direction patient care and financial health of their respective organizations As a highly sought after thought leader in the industry Bill is often cited by market researchers and analysts for his accurate predictions of future events and speaks frequently at industry conferences Micaila Ruiz Chief Pharmacy Officer Amber Pharmacy and Hy Vee Pharmacy Solutions In her current role Micaila provides leadership oversight for all operational functions including the Centers of Excellence all pharmacy locations clinical operations She oversees the development of clinical management programs for patient populations that need the exceptional high touch care that specialty pharmacies provide She started at Hy Vee Inc as a pharmacy manager and was quickly promoted to pharmacy supervisor Prior she was a regional supervisor for Health Mart She holds a doctorate of pharmacy degree from the University of Nebraska Medical Center is pursuing a master s degree in public health with a focus on health law ethics from Creighton University Mark Sasala Subject Matter Expert in Specialty Pharmacy Technology Creehan Company an Inovalon Company Mark provides consultative services guidance and industry insight to drive product innovation for the ScriptMed specialty pharmacy platform With over 25 years of healthcare IT experience including 19 years in specialty pharmacy he provides strategic direction to clients from Fortune 50 to entrepreneurial starts ups helping them leverage ScriptMed technology to support scalable customizable solutions that respond to changing business and industry dynamics He holds a MBA from Case Western Reserve University and a BS in economics from John Carroll University Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 69

PATIENT CHANNEL REPORTING DIGITAL CONCIERGE TRANSFORM YOUR SPECIALTY PHARMA DATA INTO ACTIONABLE INSIGHTS AND BRING TO LIFE WHAT S NEXT PATIENT MASTER DATA MANAGEMENT SPECIALTY DATA AGGREGATION ADVANCED ANALYTICS AI

Speakers Joseph Saseen Professor of Clinical Pharmacy Family Medicine Vice Chair Department of Clinical Pharmacy University of Colorado Denver Joseph Saseen is Professor of Clinical Pharmacy Family Medicine and Vice Chair for the Department of Clinical Pharmacy He is a clinical pharmacy specialist in family medicine is a Board Certified Pharmacotherapy Specialist a Board Certified Ambulatory Care Pharmacist a Clinical Lipid Specialist and an ASH Certified Hypertension Clinician He is Fellow of the American Society of Health System Pharmacists American College of Clinical Pharmacy and National Lipid Association Rina Shah Vice President Pharmacy Operations Walgreens Rina is VP of Pharmacy Operations and Specialty at Walgreens She began her career in various pharmacy roles at Walgreens stores in 1998 In 2007 she joined the corporate support center where she held leadership positions where she was responsible for launching innovative healthcare initiatives across the organization overseeing retail and local specialty pharmacies and leading sales operations and client services within market access Currently Rina leads a team that is responsible for pharmacy operations and specialty pharmacy across Walgreens Paula Shipp Bickley Vice President Market Access Biologics by McKesson In her current role Paula works to expand access and affordability for oncology and complex care therapies while also implementing payer solutions that drive optimal outcomes effective risk management and cost effective patient care In her 10 year career with Biologics Paula has also served as the VP of Clinician Services managing the provider facing sales team responsible for ensuring service excellence to physicians their clinical support teams and most importantly their patients who needed oral therapies and specialty pharmacy support Jonathan Silverberg Assistant Professor Dermatology Medical Social Sciences and Preventive Medicine Northwestern University Feinberg School of Medicine Jonathan Silverberg is an Associate Professor of Dermatology Medical Social Sciences and Preventive Medicine at Northwestern University Feinberg School of Medicine in Chicago IL His research interests include dermatoepidemiology health services research patient reported outcomes comorbidities and burden of inflammatory skin disease and evidence based dermatology Greg Simon President Biden Cancer Initiative Biden Cancer Initiative Greg served as the Executive Director of the White House Cancer Moonshot Task Force created by President Barack Obama for which he was chosen by VP Joe Biden Greg his team helped launch over 70 innovative collaborations He served as VP Al Gore s Chief Domestic Policy Advisor He was CEO of Poliwogg SVP for Worldwide Policy Patient Engagement at Pfizer co founded FasterCures The Center for Accelerating Medical solutions and the Melanoma Research Alliance He is a cancer survivor having been successfully treated for chronic lymphocytic leukemia Suzanne Soliman Founder Pharmacist Moms Dr Soliman earned her PharmD from the University of Illinois at Chicago She completed a residency in primary care with an emphasis on education at Midwestern University Chicago College of Pharmacy and a teaching fellowship at the University of Illinois at Chicago College of Medicine She is the Chief Academic Officer for the Accreditation Council for Medical Affairs Her areas of interest are assessment and development of medical affairs professionals For years she struggled between work life balance and the support from the Pharmacist Moms Group has really helped her 72 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

AS OF APRIL 1 2019 Richard Stefanacci Practicing Geriatrician Thomas Jefferson University Richard has served as chief medical officer for management care plans including ElderHealth Bravo HealthSpring Cigna PACE programs and currently as P T Committee member for several national plans He served as Health Policy Scholar for the Centers for Medicare Medicaid Services through Thomas Jefferson University College of Population Health He serves on the American Society of Consultant Pharmacists the American Medical Directors Association Foundation Boards and is an honorary lifetime member of ASCP the National Association of Directors of Nursing Marc Stranz Chief Clinical Officer Biomatrix Specialty Pharmacy Marc has worked for over 30 years in sterile pharmacy compounding and was an early leader in home infusion He has held branch regional and corporate positions with several national providers including SVP for Clinical Strategic Operations at Coram and VP of Clinical Operations Regulatory Affairs at BioScrip He pioneered safe and efficient provision of advanced infusion therapies at home and has sustained involvement in cutting edge therapies He is an ACHC surveyor for infusion specialty PCAB and has created several training programs for pharmacy compounding Ray Tancredi Divisional Vice President Specialty Pharmacy Development Brand Rx Vaccine Purchasing Walgreens As Divisional VP Ray Tancredi oversees a team that is responsible for all specialty pharmacy trade functions Ray joined Walgreens as Director of Trade Account Management Prior to Walgreens he worked at McKesson and held positions such as Director of Clinical Marketing Senior Account Manager and Manager of Pharmacy Services Ray started his career in Philadelphia where he owned and operated retail pharmacies with his father and brother Rite Aid Corporation acquired these pharmacies and Ray joined Aetna Inc as Area Assistant Director of Pharmacy Daniel Tardiff Chief Legal Counsel and Corporate Secretary AllianceRx Walgreens Prime At AllianceRx Walgreens Prime Dan Tardiff serves as a member of the executive leadership team for the combined central specialty and home delivery pharmacy business created by the strategic alliance between Walgreen Co and Prime Therapeutics LLC In this role Dan is the primary legal advisor to the company s C suite leadership and board of directors for all legal and corporate governance functions helping to manage central specialty and home delivery pharmacy operations in seven states across several facilities with a workforce of approximately 4 000 nationally Karen Thomas Pharmacy Supervisor Specialty Pharmacy Services University of Utah Health Karen graduated from the University Of Utah College Of Pharmacy after completing a dual PharmD PhD program earning her PhD in Pharmacology and Toxicology Karen completed a fellowship in Clinical and Applied Toxicology and earned board certification from the American Board of Applied Toxicology Karen s current role includes managing pharmacy technicians and pharmacists liaising with specialty and primary care clinics developing expansion opportunities designing workflows and ensuring excellence in the day to day activities of patient care Harry Travis President CEO EtectRx Mr Travis is the President and CEO of etectRx Inc etectRx has developed a novel wireless system that incorporates a tiny ingestible transmitter receiver into capsules to definitively reliably and safely indicate when a patient has taken their medicine He has held senior leadership positions with Baxter Healthcare Cardinal Health Accredo Medco and Aetna Most recently he was VP of Aetna s Specialty and Home Delivery Pharmacy Business Harry holds a BS in Pharmacy from the U of Pittsburgh School of Pharmacy and an MBA from The Darden School at the U of Virginia Full speaker information can be viewed at asembiasummit com specialty pharmacy summit 73

Supporting the patient journey in specialty from diagnosis and access to adherence and outcomes To learn more about our new specialty solution visit booth 310

IN A WORLD OF DISRUPTIVE CHANGE TRANSFORMATION PARTNERS YOU CAN TRUST Huron is a global consultancy that works with clients across all parts of the healthcare sector Our continuum of offerings enables the transformative change clients need to own their future Discover more by visiting www HuronConsultingGroup com 2019 Huron Consulting Group Inc and affiliates All rights reserved Helping patients start therapy faster and stay on therapy longer Patient Data Analytics Solutions Maximize your impact on the patient journey Turn patient data into actionable insights Fill gaps in specialty pharmacy data for a clear view of your patient journey Bring more actionable insights and service accountability to your specialty pharmacy relationships Identify and eliminate friction points in your patient services suite Stop by Booth 716 to see and learn more www integrichain com IntegriChain sales integrichain com 609 806 5005 Driven by Our Promise Innovation is in our DNA We are unlocking the potential of biotherapies and introducing new innovations to treat people with rare and serious diseases around the world

Speakers Paul Urick CEO URx LLC Spanning a 25 year career in managed care specialty pharmacy Paul was President of Diplomat Pharmacy President Managed Markets Industry Relations at Burmans Community Pharmacy SVP Pharmacy at Cigna Past roles include President Founder of FutureScripts FutureScripts Secure PBM companies he created as SVP Pharmacy Services for Independence BlueCross VP Pharmacy for Geisinger Health Plan He volunteers his time at the Community Volunteers In Medicine serves as Chairman of the Board of Visitors for the Philadelphia College of Pharmacy George Van Antwerp Managing Director Life Sciences and Healthcare Practice Deloitte Consulting LLP George has over 20 years of experience in the health care industry and has worked with Health Plans PBMs Specialty Pharmacies IDNs Providers and Pharmaceutical Manufacturers to help them with pharmacy strategy in the areas of consumer engagement clinical operating models and growth His work includes new product launches analytics compliance and mergers acquisitions He has also worked in the industry with Express Scripts inVentiv Health and several start ups in the consumer engagement and CRM space Gordon Vanscoy Chairman CEO PANTHERx Specialty Dr Vanscoy is the founding Chairman CEO of PANTHERx Specialty Pharmacy the nation s leader in rare disease and orphan drug specialty pharmacy PANTHERx is a quad accredited SP recognized by Inc Magazine 3 years in a row as a top 100 fastest growing companies nationwide PANTHERx Specialty Pharmacy has received back to back annual Zitter Health Insights Patient Satisfaction Award receiving the highest score ever attained quarterly Gordon has a BS in Pharmacy and MBA from the University of Pittsburgh and a Doctor of Pharmacy degree from Duquesne University Alex Vinicombe Director of Operations Management Perform Specialty With over 20 years experience in the contact center industry Alex has held leadership roles ranging from contact center operations management to call center technology support design He has managed projects in contact center design IVR automation social media marketing and workforce management He joined the specialty pharmacy industry 7 years ago and has been with PerformSpecialty since 2014 He is responsible for the Contact Center Data Analytics Technology initiatives He holds a bachelor s degree in Sociology Psychology from Saint Joseph s College New York Tuan Vu Professor Department of Neurology Division Director Neuromuscular Medicine Emg Neuromuscular Med University of South Florida Health USF Dr Vu is Professor of Neurology Director of the Neuromuscular Division EMG laboratories ALS Association Certified Treatment Center of Excellence GBS CIDP Center for Excellence at the USF He graduated from the Pennsylvania State College of Medicine He completed his Neurology residency a Neuromuscular Disease Electromyography fellowship MDA Research Fellowship at Columbia University He is the site principal investigator for clinical research trials involving patients with ALS myasthenia gravis CIDP myositis other neuromuscular conditions Geoffrey Wall Professor of Pharmacy Practice Drake University Dr Geoffrey C Wall is a Professor Department of Clinical Sciences College of Pharmacy at Drake University Director of the Drake Drug Information Center He completed an ASHP accredited Internal Medicine Specialty Residency at Scott and White Memorial Hospitals and Clinics He is Board Certified in Pharmacotherapy He is a Fellow of the American College of Clinical Pharmacy He has written a number of peer reviewed papers and textbook chapters on a variety of topics and has designed or participated in several clinical trials 76 specialty pharmacy summit Full speaker information can be viewed at asembiasummit com

Michael Zeglinski Senior Vice President Specialty Pharmacy OptumRx BriovaRx Michael Zeglinski serves as SVP Specialty Pharmacy at OptumRx He serves as CEO of the BriovaRx division OptumRx s Specialty Pharmacy He is also Green Belt certified in Lean Six Sigma processes focusing on the healthcare industry Mr Zeglinski holds a Bachelor s in Pharmacy from Duquesne University and pursued his MFA in Music from Carnegie Mellon University He is a member of the Academy of Managed Care Pharmacy and the American Pharmacists Association and has held licenses in 13 states as a registered pharmacist Jeff Zobell Advanced Clinical Pharmacist Intermountain Primary Children s Hospital and Intermountain Cystic Fibrosis Pediatric Center Jeff is an Advanced Clinical Pharmacist at the Intermountain Pediatric CF Center in Salt Lake City UT He has practiced in the area of cystic fibrosis for over 12 years the last 3 years exclusively in the outpatient CF clinic He has presented at many local national and international conferences on cystic fibrosis and has published numerous articles focused on optimization of antibiotics in CF patients and CF medication and access Dr Zobell serves as the co chairman of the CF Foundation Pharmacists Mentorship program and as a member of the CF Foundation Access Steering Committee Krista Zodet President HealthWell Foundation Ms Krista Zodet serves as President of the HealthWell Foundation Ms Zodet is responsible for developing the longterm direction of the organization in collaboration with the Board and providing strategic leadership oversight of the organization s operations programs and staff She has been a valuable member of the Foundation s management team and has over 20 years of experience in the life sciences primarily focused on patient assistance and access to care Ms Zodet received a Master s in Social Work and a B A in Sociology from the University of Michigan Ann Arbor Autumn Zuckerman Program Director Vanderbilt Specialty Pharmacy Dr Autumn Zuckerman received her Doctor of Pharmacy from Samford University McWhorter School of Pharmacy She completed 2 years of residency training at the Tennessee Valley Healthcare System VA specializing in ambulatory care She received her Board Certification in Pharmacotherapy and American Academy of HIV Medicine Pharmacy Specialist designation Soon after working at Vanderbilt Specialty Pharmacy she joined the Infectious Diseases team She was appointed Program Director of Health Outcomes and Research at Vanderbilt Specialty Pharmacy Burt Zweigenhaft Managing Partner Upstream a Biopharma Partners Company Mr Zweigenhaft is Managing Partner of Upstream a BioPharma Partners and Consultant Sr Advisor to the shareholder group of Cancer Treatment Centers of America In this role he is responsible for incubating growth and enterprise wide opportunities Previously he was CEO Vice Chairman of Onco360 a national oncology pharmacy He is Editor inChief of the Journal for Value Based Cancer Care Co Chairman Founder of the AVBCC and a Board Member PastPresident of NASP He holds a BS from the University of Buffalo

syneoshealth com Patient focused innovation Our high tech high touch approach to total drug management AT MAGELLAN RX we are passionate about driving a better patient experience around pharmaceuticals starting from the point a drug is prescribed to when it is received and ultimately taken or administered Our data driven solutions consider both traditional and medical bene t pharmacy trends as well as marketplace shifts to deliver highly personalized services and higher quality care at a lower cost Predictive analytics Digital therapeutic apps Arti cial intelligence for better adherence SHORTENING THE DISTANCE FROM LAB TO LIFE Physician decision support tools Educational videos One on one motivational interviewing coaching Take Everett and Evelyn Healthy Moving forward together And still as much in love as they were when they met in 1944 back when he was a paratrooper and she was a nurse Merck invents to Keep Love Alive Copyright 2017 Merck Sharp Dohme Corp a subsidiary of Merck Co Inc Kenilworth NJ USA All Rights Reserved CORP 1210605 0027 06 17 For more than a century Merck has been inventing medicines and vaccines for many of the world s most challenging diseases Today we re inventing new ways to treat cancer with more than 450 clinical studies underway All in an effort to help keep people healthy hopeful and allow their relationships to endure for years to come Learn more at Merck com InventingForLife INC Research and inVentiv Health have become Syneos Health the only fully integrated biopharmaceutical solutions organization with a unique approach At Syneos Health all the disciplines involved in bringing new therapies to market from clinical to commercial work together with a singular goal greatly increasing the likelihood of customer success We call our business model Biopharmaceutical Acceleration You can call it the future

Increase your temperature intelligence Complete Specialty Pharmacy Monitoring Solutions VHUBTM for Contract Pharmacies 340B Replenishment Solutions True expertise Solving 340B for pharmacies is our specialty Find out how our cutting edge solution works with your inventory system to simplify 340B and non 340B inventory replenishment Manage multiple covered entity and vendor relationships from a single platform Temperature Intelligence Asembia Booth 607 temptimecorp com www verity340b com 1 800 581 1378 2019 Verity Solutions Group Inc Trusted by the nation s leading specialty pharmacies the 1 provider of specialty pharmacy software Specialty pharmacy leaders choose CareTend by WellSky to Track orders in real time Ensure compliance Automate reporting Stop by booth 622 to see why we are 1 wellsky com rx19 1 855 wellsky sales wellsky com 1 in 340B Management Systems for the second straight year

Diamond Sponsors 80 specialty pharmacy summit

Platinum Sponsors specialty pharmacy summit 81

1 5 HOUR CE DINNER SYMPOSIUM David S Boyer MD Samit Bhatt PharmD MBA Darius M Moshfeghi MD M O N D AY A P R I L 2 9 2 0 1 9 REGISTER AT PRIMEINC ORG ASEMBIA Dinner Starts at 6 30 pm Educational Session Starts at 7 00 pm Room Margaux 2 Wynn Hotel There is no fee for this activity as it is sponsored by PRIME through an educational grant from Regeneron Pharmaceuticals Inc

Employing Immuno Oncology Biomarkers to Guide Treatment Decision Making Managed Care and Specialty Pharmacist Perspectives Continuing Education Symposium April 29 2019 Registration 4 00 4 30 PM Program 4 30 6 00 PM Wynn Meeting Room Margaux 1 Hors d oeuvres and beverages will be served LEARNING OBJECTIVES At the completion of this activity the participant will be able to Describe the potential biomarkers being examined to predict response to immunotherapy Compare the treatment options for biomarker based immunotherapy management for formulary inclusion Analyze the costs and benefits of utilizing biomarkers in determining immunotherapy treatment Describe the data that should be considered when completing the formulary review process for biomarker and immunotherapy options OVERVIEW While genomics has led the field of personalized cancer medicine over the past several decades by connecting patient specific DNA mutations with kinase targeted drugs the recent discovery that tumors evade immune surveillance has created unique challenges to personalize cancer immunotherapy Novel clinical grade biomarkers can guide the choice of these agents to obtain the maximal likelihood of patient benefit The identification of immunotherapy biomarkers enables the identification of patients most likely to derive a therapeutic response to immune checkpoint inhibitors Being able to predict who will achieve maximum benefit from therapy will not only lead to better outcomes but should positively impact healthcare expenditures as well This symposium will provide the most up to date science on contemporary uses of biomarkers in immuno oncology treatment decision making and how pharmacists can impact many aspects of both drug therapy and formulary management thus leading to improved access to care and outcomes FACULTY Lisa Davis PharmD FCCP BCPS BCOP Professor Pharmacy Practice and Science University of Arizona College of Pharmacy Oncology Clinical Pharmacist Banner University Medical Center Tucson AZ Matthew Farber MA Senior Director Patient Care Advocacy Oncology Fertility and MS Walgreens ACCREDITATION STATEMENT Postgraduate Healthcare Education LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education UAN 0430 0000 19 019 L01 P Credits 1 5 hour 0 15 ceu Type of Activity Application This educational activity is sponsored by Postgraduate Healthcare Education LLC PHE and supported by educational grants from Bristol Myers Squibb and Merck Co Inc There is no fee for attending this commercially supported symposium however seating is limited We recommend arriving early

Gold Sponsors 84 specialty pharmacy summit

Silver Sponsors specialty pharmacy summit 85

1 5 HOUR CE DINNER SYMPOSIUM Be a Part of the Discussion and Connect with Expert Faculty Using Real Time Engagement Technology Each attendee will receive a tablet for the duration of the program so register early to save your spot Nicola A Hanania MD MS FCCP Ryan J Atkinson PharmD MBA Diego J Maselli MD FCCP TU E S D AY A P R I L 3 0 2019 REGISTER AT PRIMEINC ORG ASEMBIA Dinner Starts at 6 00 pm Educational Session Starts at 6 30 pm Room Lafleur Wynn Hotel There is no fee for this activity as it is sponsored by PRIME through an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals

Join PTCE for Live CE Symposia DAY 1 MONDAY APRIL 29 2019 11 30 am 1 00 pm ROOM Lafleur Analyzing the Impact of Specialty Pharmacy Services on Outcomes in Pulmonary Arterial Hypertension Lunch will be provided This activity is supported by an independent medical education grant from Bayer HealthCare Pharmaceuticals Inc 2 00 pm 3 30 pm ROOM Lafleur Analyzing Hereditary Angioedema A Review of Evidence and Treatment Approaches Snacks will be provided This activity is supported by an independent medical education grant from CSL Behring 4 30 pm 6 00 pm ROOM Lafleur Examining Therapy Health Care Utilization and Patient Management for Chronic Inflammatory Demyelinating Polyneuropathy CIDP Snacks will be provided This activity is supported by an independent medical education grant from CSL Behring 7 00 pm 8 30 pm ROOM Lafleur PCSK9 Inhibitors Managing Hypercholesterolemia and Improving Patient Outcomes Dinner will be provided This activity is supported by an educational grant from Amgen To learn more please visit www pharmacytimes org go asembia2019

Attending Organizations 88 specialty pharmacy summit

AS OF MARCH 20 2019 specialty pharmacy summit 89

YOU RE INVITED TO ATTEND A CPE CERTIFIED LUNCH SYMPOSIUM Specialty Pharmacy Care and Cost Management Strategies for PSORIATIC DISEASE THERAPIES Monday April 29 2019 ROOM Margaux 2 Registration 11 00 am 11 30 am Wynn Hotel 3131 Las Vegas Blvd South Las Vegas NV 89109 Program 11 30 am 1 00 pm FACULTY PANEL Michael Zeglinski RPh Senior Vice President Specialty Pharmacy OptumRx BriovaRx Robin Dore MD Clinical Professor of Medicine David Geffen School of Medicine at UCLA PROGRAM DESCRIPTION Psoriasis and psoriatic arthritis presents a significant clinical and humanistic burden to patients and payers Fortunately there has been a marked increase in the number of safe and effective therapies for the disease As a result payers specialty pharmacists and affiliated providers are challenged to match patients with the most appropriate therapeutic option This program will focus on the therapeutic options available to manage the spectrum of pathologic challenges confronted by patients with psoriatic disease which can help enable specialty pharmacy professionals to improve patient quality of life and clinical outcomes LEARNING OBJECTIVES After completing this activity learners should be able to Alan Menter MD Chief Division of Dermatology Baylor University Medical Center Explain the pathophysiology and immunologic pathways of psoriatic disease Align psoriatic disease specialty drug treatment algorithms with evidence based treatment recommendations Utilize care pathways as cost management and appropriate use tools in psoriatic disease Employ specialty pharmacy and disease management services for psoriatic disease patients ACTIVITY AGENDA 11 30 am Pre Activity Learning Assessment and Opening Comments Overview Michael Zeglinski RPh 11 35 am Current Evidence Based Recommendations for the Treatment of Psoriasis Alan Menter MD 11 55 am Current Evidence Based Recommendations for the Treatment of Psoriatic Arthritis Robin Dore MD Pharmacy Credit Medical Education Resources Inc MER is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education MER designates this continuing education activity for 1 5 contact hours 0 15 CEUs of the Accreditation Council for Pharmacy Education Universal Activity Number 0816 9999 19 130 L01 P This activity is certified as Knowledge based CPE Disclosure of Conflicts of Interest It is the policy of Medical Education Resources Inc to ensure balance independence objectivity and scientific rigor in all of its educational activities In accordance with this policy MER identifies conflicts of interest with its instructors content managers and other individuals who are in a position to control the content of an activity Conflicts are resolved by MER to ensure that all scientific research referred to reported or used in a continuing education activity conforms to the generally accepted standards of experimental design data collection and analysis Fee Information No additional fee is required to attend this CPE activity however registration to the Specialty Pharmacy Summit is required AMERICANS WITH DISABILITIES ACT Event staff will be glad to assist you with any special needs ie physical dietary etc Please contact Impact Education LLC prior to the live event at 215 619 8812 12 15 pm Specialty Pharmacy Management Opportunities for Psoriatic Disease Michael Zeglinski RPh 12 45 pm Audience Q A Session Key Takeaways and Closing Comments Post Activity Assessment and Evaluation 1 00 pm Adjournment Jointly provided by TARGET AUDIENCE The target audience for this activity consists of specialty pharmacy professionals and other managed care pharmacy professionals attending the Specialty Pharmacy Summit 2019 This activity is supported by independent educational grants from Celgene Corporation Lilly USA Inc and Novartis Pharmaceuticals Corporation

YOU RE INVITED TO ATTEND A CPE CERTIFIED SYMPOSIUM MANAGI N G MULTIPLE SCLEROSIS A Guide for Specialty Pharmacy Professionals Monday April 29 2019 Registration 1 30 pm 2 00 pm Program 2 00 pm 3 30 pm ROOM Margaux 1 Wynn Hotel 3131 Las Vegas Blvd South Las Vegas NV 89109 FACULTY PANEL Edmund Pezalla MD MPH CEO Enlightenment Bioconsult LLC Harold Moses Jr MD Associate Professor of Neurology Neuroimmunology Division Vanderbilt University ACTIVITY AGENDA 2 00 pm Pre Activity Learning Assessment and Opening Comments Overview Edmund Pezalla MD MPH 2 05 pm Clinical Update on Current and Emerging MS Regimens Harold Moses Jr MD 2 50 pm Specialty Pharmacy Management Strategies to Enhance MS Patient Outcomes Edmund Pezalla MD MPH 3 20 pm Audience Q A Session Key Takeaways and Closing Comments Post Activity Assessment and Evaluation 3 30 pm Adjournment PROGRAM DESCRIPTION Despite the availability of more than a dozen disease modifying treatments DMTs health care resource utilization associated with multiple sclerosis MS is significant and continues to rise The continually evolving MS treatment landscape accentuates the need for increased disease and therapeutic knowledge amongst managed care and specialty pharmacy professionals in order to optimize clinical outcomes reduce treatment variability and increase patient engagement in their own care The expert faculty panel will discuss best practices to deliver quality care to MS patients and improve quality of life over the course of the disease LEARNING OBJECTIVES After completing this activity learners should be able to Review the safety efficacy and other attributes of emerging MS therapies Discuss recent insights into cost offsets associated with new and emerging MS therapies Employ specialty pharmacy management and benefit design strategies for MS therapies to promote appropriate prescribing Analyze care pathways and their application to manage economic outcomes in MS Pharmacy Credit Medical Education Resources Inc MER is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education MER designates this continuing education activity for 1 5 contact hours 0 15 CEUs of the Accreditation Council for Pharmacy Education Universal Activity Number 0816 9999 19 129 L01 P This activity is certified as Knowledge based CPE Disclosure of Conflicts of Interest It is the policy of Medical Education Resources Inc to ensure balance independence objectivity and scientific rigor in all of its educational activities In accordance with this policy MER identifies conflicts of interest with its instructors content managers and other individuals who are in a position to control the content of an activity Conflicts are resolved by MER to ensure that all scientific research referred to reported or used in a continuing education activity conforms to the generally accepted standards of experimental design data collection and analysis Fee Information No additional fee is required to attend this CPE activity however registration to the Specialty Pharmacy Summit is required AMERICANS WITH DISABILITIES ACT Event staff will be glad to assist you with any special needs ie physical dietary etc Please contact Impact Education LLC prior to the live event at 215 619 8812 The target audience for this activity consists of specialty pharmacy professionals and other managed care TARGET AUDIENCE Jointly provided by pharmacy professionals attending the Specialty Pharmacy Summit 2019 This activity is supported by an independent educational grant from Sanofi Genzyme

Attending Organizations 92 specialty pharmacy summit

AS OF MARCH 20 2019 specialty pharmacy summit 93

Join PTCE for Live CE Symposia DAY 2 TUESDAY APRIL 30 2019 7 00 am 8 30 am ROOM Beethoven Advancing Specialty Pharmacy s Role in the Multidisciplinary Approach to Managing Inflammatory Bowel Disease Breakfast will be provided This activity is supported by an educational grant from Takeda Pharmaceuticals U S A Inc 7 00 am 8 30 am ROOM Lafleur Novel Advances in Hereditary ATTR Amyloidosis Payer and Specialty Pharmacy Considerations Breakfast will be provided This activity is supported by an educational grant from Alnylam Pharmaceuticals 12 00 pm 1 30 pm ROOM Lafleur Early Interventions for Treating Influenza Economic Evaluation in Managed Care Settings Lunch will be provided This activity is supported by an educational grant from Genentech To learn more please visit www pharmacytimes org go asembia2019

YOU RE INVITED A VIRTUAL REALITY VIEW TO ATTEND A Moderate to Severe ATOPIC DERMATITIS SYMPOSIUM LONG TERM TREATMENT AND MANAGED CARE ISSUES TUESDAY APRIL 30 2019 11 30 AM 12 00 PM Registration Lunch 12 00 PM 1 30 PM Symposium FEATURES WYNN LAS VEGAS AND ENCORE HOTEL Meeting room Beethoven Encore 3131 Las Vegas Boulevard S Las Vegas NV Interactive case based learning environment Create your own personalized poster 1 5 CME CE ACPE CREDITS VIRTUAL REALITY SETS provided to all attendees for viewing this presentation only LIVE EVENT REGISTRATION AND SIMULCAST To preregister for the live event please visit WWW MLG ATD COM or call 207 406 4248 LEARNING OBJECTIVES FACULTY Jonathan I Silverberg MD PhD MPH Associate Professor of Dermatology Medical Social Sciences and Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL Review recent pathophysiological findings in AD that have informed the selection of new therapeutic targets Describe best practices for severity assessment and diagnosis of moderate to severe AD in adult and pediatric patients accounting for biomarkers phenotype genotype comorbidities and disease burden Explain the mechanisms of action and clinical profiles of new and emerging targeted systemic agents for the long term treatment of AD in adult and pediatric patients Discuss how different biomarkers comorbidities and adherence barriers play a role in long term treatment decision making for adults and pediatric patients with AD TARGET AUDIENCE This activity is intended for US based pharmacists managed care professionals pediatric dermatologists and other healthcare professions who diagnose treat and or manage patients with AD ACCREDITATION STATEMENT Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians CREDIT DESIGNATION STATEMENT Med Learning Group designates this live activity for a maximum of 1 5 AMA Category 1 Credit s TM Physicians should claim only the credit commensurate with the extent of their participation in the live activity NURSING CREDIT INFORMATION Purpose This program would be beneficial for nurses involved in the care of patients with atopic dermatitis Credits 1 5 ANCC Contact Hours CNE ACCREDITATION STATEMENT Ultimate Medical Academy CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center s Commission on Accreditation Geoffrey C Wall PharmD FCCP BCPS Professor of Clinical Sciences Drake University College of Pharmacy and Health Sciences Internal Medicine Clinical Pharmacist Iowa Methodist Medical Center Consulting Partner Medical Intelligence Group PLLC Des Moines IA PHARMACY CREDIT INFORMATION AMEDCO is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education Successful completion of this program qualifies for up to 1 5 contact hours Full attendance is required No partial contact hours will be awarded for partial attendance DISCLOSURE POLICY STATEMENT In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support educational programs sponsored by Med Learning Group must demonstrate balance independence objectivity and scientific rigor All faculty authors editors staff and planning committee members participating in a MLG sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer s of any commercial product s and or provider s of commercial services that are discussed in an educational activity DISCLOSURE OF UNLABELED USE Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States DISCLAIMER Med Learning Group makes every effort to develop activities that are scientifically This activity is provided by Med Learning Group This activity is co provided by Ultimate Medical Academy CCM and AMEDCO Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals based This activity is designed for educational purposes Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes Conclusions drawn by the participants should be derived from careful consideration of all available scientific information The participant should use his her clinical judgment knowledge experience and diagnostic decision making before applying any information whether provided here or by others for any professional use For questions please contact Med Learning Group at info medlearninggroup com Privacy and confidentiality policy statement information is available at www medlearninggroup com privacy policy AMERICANS WITH DISABILITIES ACT Event staff will be glad to assist you with any special needs eg physical dietary etc Please contact Med Learning Group prior to the live event at info medlearninggroup com

Attending Organizations 96 specialty pharmacy summit

AS OF MARCH 20 2019 specialty pharmacy summit 97

Join PTCE for Live CE Symposia DAY 3 WEDNESDAY MAY 1 2019 7 00 am 8 30 am ROOM Beethoven Examining von Willebrand Disease Treatment and the Role of Specialty Pharmacy Services Breakfast will be provided This activity is supported by an independent educational grant from Grifols 7 00 am 8 30 am ROOM Lafleur Examining Peanut Allergy Pathophysiology Immunotherapy Data and Health Care Utilization A Primer for Specialty Pharmacy Breakfast will be provided This activity is supported by an educational grant from Aimmune Therapeutics 12 00 pm 1 30 pm ROOM Lafleur Clinical Updates and Cost Management Strategies in Treating Idiopathic Pulmonary Fibrosis Lunch will be provided This activity is supported by an educational grant from Genentech 12 00 pm 1 30 pm ROOM Beethoven Reviewing Clinical Therapy Advances and Management of Amyotrophic Lateral Sclerosis Lunch will be provided This activity is supported by an educational grant from Mitsubishi Tanabe Pharma America Inc To learn more please visit www pharmacytimes org go asembia2019

Join PTCE for Live CE Symposia DAY 4 THURSDAY MAY 2 2019 7 00 AM 8 30 AM ROOM Lafleur Evaluating the Economic and Societal Challenges of Diabetic Retinopathy and Diabetic Macular Edema Breakfast will be provided This activity is supported by an educational grant from Genentech 7 00 am 8 30 am ROOM Beethoven Integration of PARP Inhibitors for the Treatment of Ovarian Cancer Significance for Payers and Specialty Pharmacies Breakfast will be provided This activity is supported by an educational grant from Tesaro 12 00 pm 1 30 pm ROOM Lafleur Examining Treatment Options in Chronic Thromboembolic Pulmonary Hypertension CTEPH A Review for Specialty Pharmacists Lunch will be provided This activity is supported by an educational grant from Actelion 12 00 pm 1 30 pm ROOM Beethoven Chronic Lymphocytic Leukemia Evolving Treatment Strategies and the Role of the Specialty Pharmacist in Improving Patient Outcomes Lunch will be provided This activity is supported by an educational grant from AstraZeneca To learn more please visit www pharmacytimes org go asembia2019

Attending Organizations 100 specialty pharmacy summit

AS OF MARCH 20 2019 specialty pharmacy summit 101

Attending Organizations 102 specialty pharmacy summit

AS OF MARCH 20 2019 specialty pharmacy summit 103

Exhibitors 4th Source 118 D2 Pharma Consulting 501 Accreditation Commission for Health Care 724 Decision Resources Group 734 Acute Care Pharmaceuticals 640 Diplomat 505 AdhereTech 306 Drug Topics Pharmaceutical Executive 100 Agadia 730 ECI Pharmaceuticals 630 Alvogen Inc 808 eMAX Health Systems LLC 705 Amarin Pharma Inc 834 EMD Serono Amber Pharmacy 404 EVERSANA 623 American HealthCare Capital 537 FedEx Healthcare Solutions 406 American Regent 736 Fidia Pharma USA Inc 822 Americares Foundation 828 First Financial Bank Pharmacy Lending 125 First Report Managed Care 437 AmerisourceBergen Corporation 311 111 Amgen 223 Fosun Pharma USA 529 Amneal Pharmaceuticals 328 Framework MI 540 Asembia 423 Fresenius Kabi 235 Associates of Cape Cod 135 Frier Levitt 719 Astellas Pharma US Inc 517 Genentech 329 AstraZeneca 604 Glenmark Pharmaceuticals Inc USA 816 Baswen Inc 713 GRIFOLS USA LLC 518 BioCareSD 123 Guaranteed Returns 536 Biogen 429 HealthCrowd 236 BPL 708 HealthWell Foundation 229 Breakaway Partners LLC 700 Hikma Pharmaceuticals USA Inc 804 Breckenridge Pharmaceutical Inc 642 Huron Consulting Group 316 Bula Intelligence 337 Immunoglobulin National Society 635 BusinessOne Technologies 523 Inmar Inc 340 Capgemini America Inc 723 Integra 224 Cardinal Health 511 IntegriChain 716 Caremetx 631 ISO MED INC 531 Chetu Inc 732 IQVIA 101 Cold Chain Technologies 717 Jubilant Cadista Pharmaceuticals 216 Coldkeepers 634 KeyCentrix 710 Comprehensive Pharmacy Services 217 Lannett Company Inc 824 Conduent 636 Leading Pharma ConnectiveRx 701 LexisNexis 440 Covance 120 Loopback Analytics 740 CoverMyMeds 310 McKesson 417 Creehan Company 605 Medical Accounts Receivable Solutions Inc 611 CSI Specialty Group 510 Merck 104 specialty pharmacy summit 117 323

416 Sauchik Giyaur P C Milliman 707 Senderra Specialty Pharmacy 317 Much Shelist P C 525 SensoScientific 637 National Association of Boards of Pharmacy 628 ServRx Inc 836 National Association of Specialty Pharmacy 241 Shields Health Solutions 613 Micro Merchants Systems PrimeRx 722 National Comprehensive Cancer Network 240 SHYFT 334 Nature Pack ThermalShield 729 Sobi Inc 204 Nivagen Pharmaceuticals Inc 735 Specialty Pharmacy Continuum 137 Novo Nordisk 129 Specialty Pharmacy Times 231 Omega Healthcare Services 617 Specialty Rx Source 601 Onco 360 Oncology Pharmacy 516 Stericycle 237 OptiNose Inc 830 Sun Pharma 616 PAN Foundation 207 Surescripts 105 Par Pharmaceutical 209 Taro Pharmaceuticals U S A Inc 339 Paragon Ventures 335 TemperPack 704 ParcelShield Dawson Healthcare 806 Temptime Corporation 607 Pelican Biothermal 534 Teva Pharmaceuticals 500 Perrigo Pharmaceuticals 234 The Assistance Fund 800 Pfizer Inc 405 The Braff Group 213 Pharmacists Mutual Insurance Company 319 The Compliance Team Inc 535 Pharmacy Advantage 742 The Remedy Group 711 Pharmacy Times Continuing Education PTCE 233 Therigy PharmaLink 629 TrialCard 119 211 UCB Inc 301 435 University of Pittsburgh School of Pharmacy 441 PioneerRx 641 URAC 205 Polar Tech Industries 539 Verity Solutions 810 Policy Reporter 832 Vital Care Home Infusion Services 818 ProHealth Pharmacy Solutions 733 VUCA Health 728 411 WellDyneRx 305 Wellsky 622 X GEN Pharmaceuticals Inc 307 Pillsy Pinnacle Revenue Management Prometrics QS 1 RBS Solutions 222 731 737 ReCept Pharmacy 304 ZAA Technologies LLC 436 Rees Scientific 330 Zitter Health Insights 434 Relay Network 741 RJ Health 332 Rx Relief 116 RXinsider 709 Sandoz 218 specialty pharmacy summit 105

Exhibit Hall Exhibit Hall Wynn Lafite Ballroom F B F B 810 800 804 806 808 701 705 707 709 711 713 ENTRANCE 700 816 818 822 824 828 830 832 834 836 717 719 723 729 731 733 735 737 710 716 722 724 728 730 732 734 736 611 613 617 623 629 616 622 628 630 634 636 517 523 525 529 531 535 537 605 708 607 604 511 505 631 635 637 ENTRANCE 405 404 406 ENTRANCE 101 305 307 304 306 510 516 518 411 417 311 310 205 207 209 211 213 429 416 317 319 316 318 217 323 223 329 328 330 332 642 641 640 540 539 500 301 741 740 704 601 501 742 534 536 F B 435 437 434 436 335 337 441 440 339 334 229 231 233 235 237 340 241 204 105 111 216 218 222 224 117 119 123 125 129 234 236 135 137 100 F B 106 specialty pharmacy summit ENTRANCE 116 118 120 ENTRANCE F B 240

our industry is specialty pharmacy together we are Asembia

asembia com